☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 day. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of ~~November~~August 1, ~~2022,~~2023, there were ~~207,338,160~~209,739,033 shares of the registrant’s Subordinate Voting Shares, 3,853,100 shares of the registrant’s Multiple Voting Shares (on an as converted basis) and 25,169,000 shares of the registrant’s Super Voting Shares (on an as converted basis).

In this Quarterly Report on Form 10-Q, ~~(this~~ “~~Report”),~~ unless the context otherwise requires, the terms “we,” “us,” “our,” “Company,” “Corporation” or “Green Thumb” refer to Green Thumb Industries Inc. together with its wholly-owned subsidiaries.

Unless otherwise indicated, all references to “$” or “US$” in this document refer to United States dollars, and all references to “C$” refer to Canadian dollars.

This Quarterly Report on Form 10-Q contains statements that we believe are, or may be considered to be, “forward-looking statements.” All statements other than statements of historical fact included in this document regarding the prospects of our industry or our prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “may,” “will,” “expect,” “intend,” “estimate,” “foresee,” “project,” “anticipate,” “believe,” “plan,” “forecast,” “continue” or “could” or the negative of these terms or variations of them or similar terms or expressions of similar meaning. Furthermore, forward-looking statements may be included in various filings that we make with the Securities and Exchange Commission (the “SEC”), and in press releases or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. These known and unknown risks include, without limitation: cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change; the Company may be subject to action by the U.S. federal government; state regulation of cannabis is uncertain; the Company may be subject to heightened scrutiny by Canadian regulatory authorities; the Company may face limitations on ownership of cannabis licenses; the Company may become subject to U.S. Food and Drug Administration or the U.S. Bureau of Alcohol, Tobacco Firearms and Explosives regulation; cannabis businesses are subject to applicable anti-money laundering laws and regulations and have restricted access to banking and other financial services; the Company may face difficulties acquiring additional financing; the Company faces intense competition; the Company faces competition from unregulated products; the Company is dependent upon the popularity and consumer acceptance of its brand portfolio; the Company lacks access to U.S. bankruptcy protections; the Company operates in a highly regulated sector and may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where the Company carries on business; the Company may face difficulties in enforcing its contracts; the Company has limited trademark protection; cannabis businesses are subject to unfavorable tax treatment; cannabis businesses may be subject to civil asset forfeiture; the Company is subject to proceeds of crime statutes; the Company faces exposure to fraudulent or illegal activity; the Company’s use of joint ventures may expose it to risks associated with jointly owned investments; the Company faces risks due to industry immaturity or limited comparable, competitive or established industry best practices; the Company faces risks related to its products; the ~~Company is dependent on the popularity of and consumer acceptance of the Company’s brand portfolio; the~~ Company’s business is subject to the risks inherent in agricultural operations; the Company ~~may be~~relies on third party software providers for numerous capabilities that it depends upon to operate, and a disruption of one or more systems could adversely ~~impacted by rising or volatile energy costs;~~affect the business; the Company faces risks related to its information technology systems and potential cyber-attacks and security breaches; the Company faces an inherent risk of product liability or similar claims; the Company’s products may be subject to product recalls; the Company may face unfavorable publicity or consumer perception; the Company’s voting control is concentrated; the Company’s capital structure and voting control may cause unpredictability; and issuances of substantial amounts of Super Voting Shares, Multiple Voting Shares or Subordinate Voting Shares may result in ~~dilution; and the Company is governed by corporate laws in British Columbia, Canada which in some cases have a different effect on shareholders than the corporate laws in Delaware, United States.~~dilution. Further information on these and other potential factors that could affect the Company’s business and financial condition and the results of operations are included in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, and elsewhere in the Company’s filings with the SEC, which are available on the SEC’s website or at https://investors.gtigrows.com. Readers are cautioned not to place undue reliance on any forward-looking statements contained in this document, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements. You are advised, however, to consult any additional disclosures we make in our reports to the SEC. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this document.


	September 30,			December 31,			June 30,			December 31,
	2022			2021			2023			2022
				(Audited)						(Audited)
	(in thousands)						(in thousands)
ASSETS
Current Assets:
Cash and Cash Equivalents	$	147,258		$	230,420		$	149,026		$	177,682
Accounts Receivable		30,638			22,099
Accounts Receivable, Net								39,240			30,975
Income Tax Receivable								5,335			7,473
Inventories		121,922			95,471			124,772			115,675
Prepaid Expenses		14,003			11,175			14,202			13,364
Other Current Assets		4,739			5,065			8,679			6,182
Total Current Assets		318,560			364,230			341,254			351,351
Property and Equipment, Net		498,348			409,074			674,958			557,873
Right of Use Assets, Net		243,371			176,327			239,964			242,357
Investments		79,981			94,902			75,060			74,169
Investments in Associates		27,384			30,337			25,358			25,508
Intangible Assets, Net		640,988			675,491			564,165			589,519
Goodwill		644,585			632,849			589,691			589,691
Deposits and Other Assets		2,663			2,641			2,384			3,060
TOTAL ASSETS	$	2,455,880		$	2,385,851		$	2,512,834		$	2,433,528
LIABILITIES AND SHAREHOLDERS' EQUITY
LIABILITIES
Current Liabilities:
Accounts Payable	$	14,083		$	14,086		$	27,494		$	18,423
Accrued Liabilities		71,516			84,724			116,890			86,971
Acquisition Consideration Payable		—			31,732
Compensation Payable		11,393			12,022			7,809			13,476
Current Portion of Notes Payable		1,027			783			1,048			1,037
Current Portion of Lease Liabilities		10,334			9,221			12,245			10,906
Contingent Consideration Payable		12,121			50,284			—			11,400
Income Tax Payable		8,965			1,527			9,775			4,358
Total Current Liabilities		129,439			204,379			175,261			146,571
Long-Term Liabilities:
Lease Liabilities, Net of Current Portion		249,446			182,539			248,328			249,281
Notes Payable, Net of Current Portion and Debt Discount		254,504			239,151			288,857			274,631
Contingent Consideration Payable		29,829			33,581			32,022			30,543
Warrant Liability		5,001			24,877			—			4,520
Deferred Income Taxes		80,854			81,846			62,550			62,550
TOTAL LIABILITIES		749,073			766,373			807,018			768,096
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY
Subordinate Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2022: Unlimited, 206,753,924, and 206,753,924, respectively, at December 31, 2021: Unlimited, 201,768,312, and 201,768,312, respectively)		—			—
Multiple Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2022: Unlimited, 38,531 and 38,531, respectively, at December 31, 2021: Unlimited, 38,531 and 38,531, respectively)		—			—
Super Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2022: Unlimited, 251,690 and 251,690, respectively, at December 31, 2021: Unlimited, 285,031 and 285,031, respectively)		—			—
Subordinate Voting Shares (Shares Authorized, Issued and Outstanding at June 30, 2023: Unlimited, 208,976,040, and 208,976,040, respectively, at December 31, 2022: Unlimited, 206,991,275, and 206,991,275, respectively)								—			—
Multiple Voting Shares (Shares Authorized, Issued and Outstanding at June 30, 2023: Unlimited, 38,531 and 38,531, respectively, at December 31, 2022: Unlimited, 38,531 and 38,531, respectively)								—			—
Super Voting Shares (Shares Authorized, Issued and Outstanding at June 30, 2023: Unlimited, 251,690 and 251,690, respectively, at December 31, 2022: Unlimited, 251,690 and 251,690, respectively)								—			—
Share Capital		1,660,799			1,633,672			1,693,429			1,663,557
Contributed Surplus		16,325			21,245			34,421			23,233
Deferred Share Issuances		36,262			36,262			12,973			36,211
Accumulated Deficit		(6,858	)		(70,063	)		(35,546	)		(58,085	)
Equity of Green Thumb Industries Inc.		1,706,528			1,621,116			1,705,277			1,664,916
Noncontrolling interests		279			(1,638	)		539			516
TOTAL SHAREHOLDERS' EQUITY		1,706,807			1,619,478			1,705,816			1,665,432
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$	2,455,880		$	2,385,851		$	2,512,834		$	2,433,528

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

Three and ~~Nine~~Six Months Ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022


		Three Months Ended September 30,								Nine Months Ended September 30,								Three Months Ended June 30,								Six Months Ended June 30,
		2022				2021				2022				2021				2023				2022				2023				2022
		(in thousands)								(in thousands)								(in thousands)								(in thousands)
Revenues, Net of Discounts	$		261,194		$		233,677		$		758,105		$		649,979		$		252,388		$		254,311		$		500,924		$		496,911
Cost of Goods Sold, Net			(129,954	)			(104,159	)			(378,127	)			(286,685	)			(127,108	)			(128,513	)			(250,923	)			(248,173	)
Gross Profit			131,240				129,518				379,978				363,294				125,280				125,798				250,001				248,738
Expenses:
Selling, General, and Administrative			82,479				71,449				214,402				202,836				84,217				63,535				164,736				131,923
Total Expenses			82,479				71,449				214,402				202,836				84,217				63,535				164,736				131,923
Income From Operations			48,761				58,069				165,576				160,458				41,063				62,263				85,265				116,815
Other Income (Expense):
Other Income (Expense), Net			(2,085	)			8,125				14,933				9,805				(270	)			5,583				654				17,018
Interest Income, Net			1,085				328				2,609				674				1,531				624				3,262				1,524
Interest Expense, Net			(4,644	)			(7,616	)			(16,113	)			(16,419	)			(2,869	)			(5,399	)			(6,685	)			(11,469	)
Total Other Income (Expense)			(5,644	)			837				1,429				(5,940	)			(1,608	)			808				(2,769	)			7,073
Income Before Provision for Income Taxes And Non-Controlling Interest			43,117				58,906				167,005				154,518				39,455				63,071				82,496				123,888
Provision For Income Taxes			32,969				37,320				102,440				98,203				25,765				38,340				59,401				69,471
Net Income Before Non-Controlling Interest			10,148				21,586				64,565				56,315				13,690				24,731				23,095				54,417
Net Income Attributable to Non-Controlling Interest			319				1,376				1,360				3,685				290				294				556				1,041
Net Income Attributable To Green Thumb Industries Inc.	$		9,829		$		20,210		$		63,205		$		52,630		$		13,400		$		24,437		$		22,539		$		53,376
Net Income Per Share - Basic	$		0.04		$		0.09		$		0.27		$		0.24		$		0.05		$		0.11		$		0.09		$		0.23
Net Income Per Share - Diluted	$		0.04		$		0.08		$		0.26		$		0.23		$		0.05		$		0.10		$		0.09		$		0.22
Weighted Average Number of Shares Outstanding - Basic			237,002,873				226,529,671				236,546,078				221,059,870				238,000,135				236,783,625				237,700,856				236,313,896
Weighted average Number of Shares Outstanding - Diluted			237,804,799				230,879,437				237,872,595				225,411,773				238,423,288				237,762,903				239,455,964				237,869,300

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity

Three and ~~Nine~~Six Months Ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity

Three and ~~Nine~~Six Months Ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements


	Nine Months Ended September 30,						Six Months Ended June 30,
	2022			2021			2023			2022
	(in thousands)						(in thousands)
CASH FLOW FROM OPERATING ACTIVITIES
Net income attributable to Green Thumb Industries Inc.	$	63,205		$	52,630		$	22,539		$	53,376
Net income attributable to non-controlling interest		1,360			3,685			556			1,041
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		71,706			47,239			47,735			47,188
Amortization of operating lease assets		31,906			24,760			24,368			20,022
Loss on extinguishment of debt		—			9,882
Loss on disposal of property and equipment		1,514			822			1,951			100
Loss (earnings) on equity method investment		2,382			(1,330	)
Impairment of long-lived property and equipment								285			—
Loss on equity method investments								750			1,941
Gain from lease modification		(3,330	)		—			—			(3,330	)
Bad debt expense		190			264
Deferred income taxes		—			8,217
Stock-based compensation		19,362			14,698			13,620			11,484
Decrease (increase) in fair value of investments		2,770			(14,604	)
Interest on contingent consideration payable and acquisition liabilities		2,782			2,874
(Decrease) increase in fair value of contingent consideration		(31,787	)		662
Decrease in fair value of investments								928			3,201
Increase (decrease) in fair value of contingent consideration								2,150			(29,960	)
Decrease in fair value of warrants		(19,876	)		(5,451	)		(2,263	)		(21,772	)
Shares issued for settlement of business obligation		1,000			7,135			—			1,000
Gain on indemnification of deferred shares associated with post acquisition costs								(2,784	)		—
Amortization of debt discount		6,837			4,954			4,762			4,559
Changes in operating assets and liabilities:
Accounts receivable		(8,881	)		(3,782	)
Inventories		(26,038	)		(17,257	)
Accounts receivable, net								(8,265	)		(3,952	)
Inventories, net								(9,097	)		(27,361	)
Prepaid expenses and other current assets		(2,419	)		(5,993	)		(3,285	)		(996	)
Deposits and other assets		(22	)		(979	)		676			(147	)
Accounts payable		(259	)		(12,950	)		9,071			5,779
Accrued liabilities		(4,021	)		3,517			3,365			(9,998	)
Operating lease liabilities		(27,599	)		(20,345	)		(21,589	)		(17,234	)
Income tax payable		7,438			(15,881	)
Income tax receivable and payable, net								7,555			4,973
NET CASH PROVIDED BY OPERATING ACTIVITIES		88,220			82,767			93,028			39,914
CASH FLOW FROM INVESTING ACTIVITIES
Purchases of property and equipment		(119,870	)		(117,160	)		(129,392	)		(71,131	)
Proceeds from disposal of property and equipment		112			109			319			32
Investments in securities and associates		(5,804	)		(31,053	)		(2,800	)		(5,453	)
Proceeds from equity investments and notes receivable		3,476			18,282			331			1,243
Settlement of acquisition consideration payable		(31,732	)		—			—			(31,732	)
Purchase of businesses, net of cash acquired		(7,350	)		(18,458	)		—			(7,255	)
NET CASH USED IN INVESTING ACTIVITIES		(161,168	)		(148,280	)		(131,542	)		(114,296	)
CASH FLOW FROM FINANCING ACTIVITIES
Distributions to third parties and limited liability company unit holders		(14,799	)		(8,252	)
Distributions to limited liability company unit holders								(533	)		(14,445	)
Contributions from unconsolidated subsidiaries		550			1,476			—			550
Net proceeds from issuance of registered shares pursuant to Form S-1		—			155,498
Proceeds from exercise of options and warrants		2,684			11,228
Proceeds from exercise of options and RSUs								916			1,603
Proceeds from issuance of notes payable		2,102			175,500			10,134			2,102
Principal repayment of notes payable		(751	)		(64,703	)		(659	)		(571	)
Prepayment penalty and other costs associated with refinancing		—			(3,200	)
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES		(10,214	)		267,547
CASH, CASH EQUIVALENTS AND RESTRICTED CASH:
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH		(83,162	)		202,034
CASH, CASH EQUIVALENTS AND RESTRICTED CASH BEGINNING OF PERIOD		230,420			83,758
CASH, CASH EQUIVALENTS AND RESTRICTED CASH END OF PERIOD	$	147,258		$	285,792
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES								9,858			(10,761	)
CASH AND CASH EQUIVALENTS:
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS								(28,656	)		(85,143	)
CASH AND CASH EQUIVALENTS BEGINNING OF PERIOD								177,682			230,420
CASH AND CASH EQUIVALENTS END OF PERIOD							$	149,026		$	145,277

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements


	Nine Months Ended September 30,						Six Months Ended June 30,
	2022			2021			2023			2022
	(in thousands)						(in thousands)
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid	$	13,699		$	13,714		$	10,086		$	9,028
NONCASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	$	(10,217	)	$	12,869		$	12,630		$	(3,761	)
Noncash increase in right of use asset	$	(72,714	)	$	(22,620	)	$	(3,928	)	$	(69,821	)
Noncash increase in lease liability	$	72,714		$	22,620		$	3,928		$	69,821
Warrant issuance associated with note payable	$	—		$	22,530
Mortgages associated with operating properties	$	7,350		$	6,830
Shares issued for purchase of noncontrolling interest	$	2,379		$	4,070		$	—		$	2,379
Issuance of shares associated with contingent consideration	$	13,111		$	18,622		$	6,070		$	13,111
Deferred share issuances	$	—		$	29,196
Deferred share distributions	$	—		$	(3,138	)	$	(20,454	)	$	—
Issuance of shares under business combinations	$	1,406		$	223,979		$	—		$	1,406
Acquisitions
Inventories	$	413		$	6,183		$	—		$	413
Accounts receivable		(153	)		552			—			(370	)
Prepaid expenses		72			367			—			72
Property and equipment		738			15,705			—			738
Right of use assets		743			18,325			—			743
Intangible assets		10,359			173,926
Identifiable Intangible assets								—			14,143
Goodwill		11,736			214,786			—			8,869
Deposits and other assets		12			904			—			12
Liabilities assumed		(712	)		(11,032	)		—			(466	)
Lease liabilities		(743	)		(18,325	)		—			(743	)
Noncontrolling interests		17,735			—			—			17,735
Contingent liabilities		(200	)		(61,853	)
Equity interests issued		(3,785	)		(285,339	)		—			(3,785	)
Fair value of previously held equity interest		(14,500	)		—			—			(14,500	)
Deferred income taxes		991			(35,741	)
Deferred cash								—			(250	)
Settlement of noncontrolling interests		(15,356	)		—			—			(15,356	)
	$	7,350		$	18,458		$	—		$	7,255
ADDITIONAL SUPPLEMENTAL INFORMATION
Decrease (increase) in fair value of investments	$	16,889		$	(14,604	)
Decrease in fair value of investments							$	928		$	17,320
Increase in fair value of equity method investments		(14,119	)		—			—			(14,119	)
TOTAL DECREASE (INCREASE) IN FAIR VALUE OF INVESTMENTS	$	2,770		$	(14,604	)
TOTAL DECREASE IN FAIR VALUE OF INVESTMENTS							$	928		$	3,201

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

1. Overview and Basis of Presentation

(a) Description of Business

Green Thumb Industries Inc. (“Green ~~Thumb”~~Thumb,” the “Company,” “we” or ~~the “Company”~~“us”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while being committed to community and sustainable, profitable growth. Green Thumb owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including &Shine, Beboe, Dogwalkers, ~~Dr.~~Doctor Solomon’s, Good Green, incredibles, and RYTHM, to third-party retail stores across the United States as well as to Green Thumb owned ~~Retail~~retail cannabis stores. The Company also owns and operates retail cannabis stores that include a rapidly growing national chain named RISE, which sell our products and third-party products. As of ~~September~~June 30, ~~2022,~~2023, Green Thumb has ~~operations~~revenue in fifteen markets (California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia), employs approximately ~~3,800~~4,300 people and serves ~~hundreds of thousands~~millions of patients and customers annually.

The Company’s registered office is located at 250 Howe Street, 20th Floor, Vancouver, British Columbia, V6C 3R8. The Company’s U.S. headquarters are at 325 W. Huron St., Suite 700, Chicago, IL 60654.

(b) Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, ~~2021,~~2022, (the ~~“2021~~"2022 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited ~~interim~~ condensed consolidated financial statements. Actual results could differ from these estimates.

There have been no changes to the Company’s significant accounting policies as described in ~~Part II, Item 8,~~ “~~Notes~~Note 2 to the Company's Consolidated Financial ~~Statements”, Note 2 - Significant Accounting Policies~~Statements included in the ~~2021~~2022 Form 10-K.

(d) Earnings per Share

Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of ~~September~~June 30, 2023, the Company had 10,874,051 options, 3,453,460 restricted stock units and 3,734,555 warrants outstanding. As of June 30, 2022, the Company had ~~9,725,907~~6,036,849 options, ~~952,753~~1,024,659 restricted stock units and 3,835,278 warrants outstanding. ~~As of September 30, 2021, the Company had~~ ~~5,625,661~~ ~~options,~~ ~~352,936~~ ~~restricted stock units and~~ ~~3,591,975~~ ~~warrants outstanding.~~

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

1. Overview and Basis of Presentation (Continued)

(d) Earnings per Share (Continued)

In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended ~~September~~June 30, 2023, the computation of diluted earnings per share included 135,894 options, 287,259 restricted stock units. For the six months ended June 30, 2023, the computation of diluted earnings per share included 167,191 options, 1,587,917 restricted stock units. There were no dilutive warrants during the three and six months ended June 30, 2023 as the strike price was greater than the average stock price for the period. For the three months ended June 30, 2022, the computation of diluted earnings per share included ~~697,800~~842,440 options, ~~57,128~~34,451 restricted stock units and ~~46,998~~102,387 warrants. For the ~~nine~~six months ended ~~September~~June 30, 2022, the computation of diluted earnings per share included ~~968,322~~1,310,817 options, ~~226,564~~34,618 restricted stock units and ~~131,631~~209,969 warrants. For the three and six months ended ~~September~~June 30, ~~2021,~~2023, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share ~~included~~were ~~3,022,973~~3,399,518 ~~options,~~ ~~223,661~~ ~~restricted stock units~~ and ~~1,103,132~~3,473,866 ~~warrants. For the nine months ended September 30, 2021, the computation of diluted earnings per share included~~ ~~3,041,286~~ ~~options,~~ ~~196,043~~ ~~restricted stock units and~~ ~~1,114,574~~ ~~warrants.~~, respectively. For the three and ~~nine~~six months ended ~~September~~June 30, 2022, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were ~~2,052,822~~1,643,117 and ~~2,192,896, respectively. For the three and nine months ended September 30, 2021, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were~~ ~~570,964~~ ~~and~~ ~~913,579~~1,400,582, respectively.

~~(e)~~ ~~Recently Adopted Accounting Standards~~

~~In August 2020, the Financial Accounting Standards Board (“FASB”~~) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, to improve financial reporting associated with accounting for convertible instruments and contracts in an entity’s own equity. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. The Company adopted ASU 2020-06 on January 1, 2022. The adoption of the standard did not have a material impact on the Company's unaudited interim condensed consolidated financial statements.

~~(f)~~(e) Recently Issued Accounting Standards

The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no standards yet to be adopted which are relevant to the business for disclosure.

~~(g)~~ ~~Coronavirus Pandemic~~

In March 2020, the World Health Organization categorized coronavirus disease 2019 (together with its variants, “COVID-19”) as a pandemic. COVID-19 continues to spread throughout the U.S. and other countries across the world, and the duration and severity of its effects are currently unknown. The Company continues to implement and evaluate actions to strengthen its financial position and support the continuity of its business and operations.

The Company’s unaudited interim condensed consolidated financial statements presented herein reflect estimates and assumptions made by management that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited interim condensed consolidated financial statements and reported amounts of revenue and expenses during the periods presented. Such estimates and assumptions affect, among other things, the Company’s goodwill; long-lived assets and intangible assets; operating lease right of use assets and operating lease liabilities; valuation of deferred income taxes; the allowance for doubtful accounts; assessment of the Company’s lease and non-lease contract expenses; and measurement of compensation cost for bonus and other compensation plans. While the Company’s revenue, gross profit and operating income were not impacted during the first nine months of 2022, the uncertain nature of the spread of COVID-19 and the uncertainty of the impact of nationwide vaccine programs may impact the Company’s business operations for reasons including the potential quarantine of the Company’s employees or those of its supply chain partners.

5. INTANGIBLE ASSETS AND GOODWILL

(a) Intangible Assets

Intangible assets are recorded at cost less accumulated amortization and impairment losses, if any. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively.

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, intangible assets consisted of the following:

September 30, 2022

December 31, 2021

Gross Carrying Amount

Accumulated Amortization

Net Book Value

Gross Carrying Amount

Accumulated Amortization

Net Book Value

(in thousands)

(in thousands)

Licenses and Permits
$

666,259

$

102,922

$

563,337

$

655,900

$

69,812

$

586,088

Trademarks

98,936

33,859

65,077

98,936

25,096

73,840

Customer Relationships

24,438

12,563

11,875

24,438

9,944

14,494

Non-Competition Agreements

2,565

1,866

699

2,565

1,496

1,069

Total Intangible Assets
$

792,198

$

151,210

$

640,988

$

781,839

$

106,348

$

675,491


		June 30, 2023						December 31, 2022
		Gross Carrying Amount		Accumulated Amortization		Net Book Value		Gross Carrying Amount		Accumulated Amortization		Net Book Value
		(in thousands)						(in thousands)
Licenses and Permits	$	660,716	$	135,716	$	525,000	$	660,716	$	113,800	$	546,916
Trademarks		41,511		11,932		29,579		41,511		10,486		31,025
Customer Relationships		24,438		15,181		9,257		24,438		13,435		11,003
Non-Competition Agreements		2,565		2,236		329		2,565		1,990		575
Total Intangible Assets	$	729,230	$	165,065	$	564,165	$	729,230	$	139,711	$	589,519

The Company recorded amortization expense for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 of $~~14,823~~12,744 thousand and $~~44,862~~25,354 thousand, respectively. The Company recorded amortization for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 of $~~10,938~~15,097 thousand and $~~30,984~~30,039 thousand, respectively.

The following table outlines the estimated annual amortization expense related to intangible assets as of ~~September~~June 30, ~~2022:~~2023:


		Estimated Amortization		Estimated Amortization
Year Ending December 31,		(in thousands)		(in thousands)
Remainder of 2022	$	15,034
2023		60,136
Remainder of 2023			$	25,487
2024		59,554		50,392
2025		59,457		50,294
2026		51,445		47,332
2027 and Thereafter		395,362
2027				46,803
2028 and Thereafter				343,857
	$	640,988	$	564,165

As of ~~September~~June 30, ~~2022,~~2023, the weighted average amortization period remaining for intangible assets was ~~12.11~~11.84 years.

(b) Goodwill

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 the balances of goodwill, by segment, consisted of the following:

Retail

Consumer Package Goods

Total

(in thousands)
As of December 31, 2021
$
274,811
$
358,038
$
632,849
Acquisition of ILDISP, LLC

7,718

—

7,718
Adjustments to Preliminary Purchase Price Allocations

3,776

242

4,018
As of September 30, 2022
$
286,305
$
358,280
$
644,585


		Retail		Consumer Packaged Goods		Total
		(in thousands)
As of December 31, 2022	$	273,802	$	315,889	$	589,691
As of June 30, 2023	$	273,802	$	315,889	$	589,691

6.5. INVESTMENTS

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company held various equity interests in cannabis related companies as well as investments in ~~convertible notes~~note receivable instruments that had a combined fair value of $~~79,981~~75,060 thousand and $~~94,902~~74,169 thousand as of each period end, respectively. The Company measures its investments that do not have readily determinable fair value at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company performs an assessment on a quarterly basis to determine whether triggering events for impairment exist and to identify any observable price changes.

The following table summarizes the changes in the Company’s investments during the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and year ending December 31, ~~2021:~~2022:


		September 30, 2022		December 31, 2021		June 30, 2023		December 31, 2022
	(in thousands)				(in thousands)
Beginning	$	94,902	$	40,795	$	74,169	$	94,902
Additions		5,444		83,689		2,200		5,444
Disposals		(3,476)		(18,417)		(331)		(3,571)
Fair value adjustment		(16,889)		6,377		(928)		(22,606)
Transfers out		—		(17,542)
Transfers and other						(50)		—
Ending	$	79,981	$	94,902	$	75,060	$	74,169

During the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the Company recorded fair value ~~gains (losses)~~losses, net of interest income of $~~432~~577 thousand and $(~~16,889) thousand, respectively, of which~~ $~~247~~928 thousand, respectively. The fair value losses associated with the Company's equity investments in the amount of $655 thousand and $($~~17,368~~1,134) thousand as of the three and six months ended June 30, 2023, respectively, was recorded within other income (expense)~~, respectively, and~~ on the Company's unaudited interim condensed consolidated statements of operations. The interest income portion associated with the Company's note receivable investments in the amount of $~~185~~78 thousand and $~~479~~206 thousand as of the three and six months ended June 30, 2023, respectively ~~related to various note receivable investments and~~ was recorded towithin interest income on the unaudited interim condensed consolidated statements of operations.

(a) Equity Investments

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company held equity investments in publicly traded entities which have readily determinable fair values, which are classified as Level 1 investments, of $~~4,022~~1,370 thousand and $~~20,583~~2,535 thousand, respectively. During the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the Company recorded net ~~gains (losses)~~losses on the change in fair value of such investments of $~~124~~655 thousand and $(~~14,169~~) thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statement of operations. During the three and nine months ended September 30, 2021, the Company recorded net gains (losses) on the change in fair value of such investments of $(~~4,282) thousand and~~ $~~9,630~~1,134 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated ~~statement~~statements of operations. During the ~~nine~~three and six months ended ~~September~~June 30, 2022, the Company recorded net losses on the change in fair value of such investments of $6,396 thousand and ~~2021,~~$14,293 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statements of operations. During the six months ended June 30, 2023 and 2022, the Company received proceeds from the sale of such investments of $~~2,393~~31 thousand and $~~18,282~~160 thousand, respectively. These investments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company held equity investments in privately held entities that did not have readily determinable fair values, which are classified as Level 3 investments, of $~~42,030~~42,330 thousand and $~~33,066~~40,330 thousand, respectively. For the three and six months ended June 30, 2023, there were no gains or losses on the change in fair value of such investments. During the three and ~~nine~~six months ended ~~September~~June 30, 2022, the Company recorded net gains ~~(losses)~~ on the change in fair value of such investments of $($~~295~~22) thousand and $~~182~~477 thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated ~~statement of operations. During the three and nine months ended September 30, 2021, the Company recorded net gains (losses) on the change in fair value of such investments of $~~0 ~~thousand and $4,766~~ ~~thousand, respectively, within other income (expense) on the unaudited interim condensed consolidated statement~~statements of operations. There were no sales of these investments during these periods. These investments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

See Note 1413 - Fair Value Measurements for additional details.

1514

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

6.5. INVESTMENTS (Continued)

(a) Equity Investments (Continued)

Unrealized gains and (losses) recognized on equity investments held during the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 were $~~137~~ ~~thousand and~~ $(~~13,825~~653) thousand and $1,996 thousand, respectively. Unrealized ~~gains and (losses)~~losses recognized on equity investments held during the three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 were $(~~4,140~~6,367) thousand and $$(~~14,596~~13,792) thousand, respectively.

(b) ~~Convertible Notes~~Note Receivable Instruments

The Company has made multiple investments in various note receivable instruments, including note receivable instruments with conversion features.

~~As of September 30, 2022 and December 31, 2021, the~~The Company held note receivable instruments, which were classified as a Level 1 investment as they represent public debt of a publicly traded entity, and had a fair value of $~~22,213~~22,214 thousand as of June 30, 2023 and $~~23,534~~ ~~thousand, respectively.~~December 31, 2022. During the three and ~~nine~~six months ended ~~September~~June 30, 2023, there were no gains or (losses) on the change in fair value of such investments. For the three and six months ended June 30, 2022, the Company recorded net ~~gains (losses)~~losses on the change in fair value of such investments of $~~418~~378 thousand and $($~~236~~654) thousand, respectively within other income (expense) on the unaudited interim condensed consolidated ~~statement~~statements of operations. ~~There were~~ no gains or (losses) recognized on these investments during the three and nine months ended September 30, 2021. The Company received proceeds from the partial principal repayment of the note receivable of $~~1,083~~ ~~thousand during the nine months ended September 30, 2022.~~ The note receivable instruments have a stated interest rate of ~~13.00~~13% and a maturity date of April ~~29, 2025~~.30, 2025. These ~~notes~~note receivable instruments did not contain conversion features and are currently classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company held note receivable instruments which were classified as Level 3 investments as they represent loans provided to privately held entities that do not have readily determinable fair values. The note receivable instruments had a combined fair value of $~~11,716~~9,146 thousand and $~~17,719~~9,090 thousand, respectively, with stated interest ranging between 0.91% ~~and~~- ~~10.00~~10% and terms between 15 months to five years. During the three and ~~nine~~six months ended ~~September~~June 30, ~~2022, the Company~~2023, there were no gains or (losses) recorded ~~net gains (losses)~~ on the change in fair value of such investments, ~~of $~~0 ~~thousand and $(3,145) thousand, respectively, within other income (expense) and~~however, the company recorded accrued interest of $~~185~~78 thousand and $~~479~~206 thousand, respectively, within interest income on the unaudited interim condensed consolidated ~~statement~~statements of operations. During the three and ~~nine~~six months ended ~~September~~June 30, ~~2021, there were~~ 2022, the Company recorded net losses on the change in fair value of such investments of $no1,266 ~~gains or (losses) recognized on these investments~~thousand and $3,157 thousand, respectively, within other income (expense)~~, however the company recorded~~ and accrued interest of $~~133~~153 thousand and $~~208~~307 thousand, respectively, within interest income on the unaudited interim condensed consolidated ~~statement~~statements of operations. These ~~notes~~note receivable instruments are classified as trading securities on the Company's unaudited interim condensed consolidated balance sheets.

See Note 1413 - Fair Value Measurements for additional details.

7.6. LEASES

(a) Operating Leases

The Company has operating leases for its retail stores and processing and cultivation facilities located throughout the ~~U.S,~~U.S., as well as ~~for~~ corporate office space located in Illinois. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date.

All real estate leases are recorded on the balance sheet. Equipment and other non-real estate leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease agreements for some locations provide for rent escalations and renewal options. Certain real estate leases require payment for fixed and variable non-lease components, such as taxes, insurance and maintenance. The Company accounts for each real estate lease and the related non-lease components together as a single component.

The Company determines if an arrangement is a lease at inception. The Company must consider whether the contract conveys the right to control the use of an identified asset. Certain arrangements require significant judgment to determine if an asset is specified in the contract and if the Company directs how and for what purpose the asset is used during the term of the contract. For the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the Company recorded operating lease expense of $~~11,884~~12,146 thousand and $~~31,906~~24,368 thousand, respectively compared to operating lease expense of $~~8,733~~10,201 thousand and $~~24,760~~20,022 thousand for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, respectively.

Other information related to operating leases as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 were as follows:


	September 30, 2022	December 31, 2021	June 30, 2023	December 31, 2022
Weighted average remaining lease term (years)	12.05	11.82	12.17	11.64
Weighted average discount rate	12.44%	13.60%	12.46%	12.42%

Maturities of lease liabilities for operating leases as of ~~September~~June 30, ~~2022~~2023 were as follows:

Maturities of Lease Liability
Year Ending December 31,

Third Party

Related Party

Total

(in thousands)
Remainder of 2022
$
10,142
$
282
$
10,424
2023

41,368

1,144

42,512
2024

41,068

1,027

42,095
2025

38,748

948

39,696
2026

37,029

970

37,999
2027 and Thereafter

378,332

7,066

385,398
Total Lease Payments

546,687

11,437

558,124
Less: Interest

                        (293,231)

                           (5,113)

                   (298,344)
Present Value of Lease Liability
$
253,456
$
6,324
$
259,780


		Maturities of Lease Liability
Year Ending December 31,		Third Party		Related Party		Total
		(in thousands)
Remainder of 2023	$	21,641	$	287	$	21,928
2024		43,304		437		43,741
2025		41,087		343		41,430
2026		39,391		350		39,741
2027		39,672		357		40,029
2028 and Thereafter		352,023		1,728		353,751
Total Lease Payments		537,118		3,502		540,620
Less: Interest		(278,715)		(1,332)		(280,047)
Present Value of Lease Liability	$	258,403	$	2,170	$	260,573

(b) Related Party Operating Leases

The Company ~~entered into~~has leasing arrangements that are related party transactions ~~with respect to its leasing arrangements~~including for certain facilities in ~~Florida,~~ Maryland, Massachusetts and Nevada. Wendy Berger, a director of the Company, is a principal of WBS Equities, LLC, which is the Manager of Mosaic Real Estate, LLC, and owns the ~~applicable~~ facilities leased by the Company. Additionally, Mosaic Real Estate, LLC is indirectly owned in part by Ms. Berger (through the Wendy Berger 1998 Revocable Trust), Benjamin Kovler, the Chairman and Chief Executive Officer ~~and a director~~ of the Company (through KP Capital, LLC), and Anthony Georgiadis, the ~~Chief Financial Officer~~President and a director of the Company (through Three One Four Holdings, ~~LLC and ABG, LLC) and William Gruver, a former director of the Company (held through ABG,~~ LLC). The terms of these leases range from 7 years

~~Green Thumb Industries Inc.~~

~~Notes to Unaudited Interim Condensed Consolidated Financial Statements~~

~~(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)~~

~~7. LEASES~~ ~~(Continued)~~

~~(b) Related Party Operating Leases~~ ~~(Continued)~~

to 15 years. For the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the Company recorded lease expense of $~~296~~137 thousand and $~~886~~276 thousand, respectively, compared to lease expense of $296 thousand and $~~891~~589 thousand for the three and ~~nine~~six months ended ~~September~~June 30, ~~2021, respectively, associated with these related party leasing arrangements.~~2022, respectively.

On June 29, 2022 the Company entered into the third amendment (the “Amendment”) to its existing lease agreement with Innovative Industrial Properties, Inc. (“IIP”) associated with its Danville, Pennsylvania cultivation and processing facility. The Amendment provided an additional tenant improvement allowance of $~~55,000~~ ~~thousand to be used on enhancements to the facility. In addition to the tenant improvement allowance of $19,300~~ ~~thousand received in prior years, the total tenant improvement allowance provided by IIP will be $74,300~~ ~~thousand, and brings IIP's total investment in the property to $94,600~~ ~~thousand. The Amendment to the lease was treated as a modification and resulted in a gain of $3,061~~ ~~thousand as well as an increase in the right of use asset and related lease liability of $81,720~~ ~~thousand.~~

8.7. NOTES PAYABLE

At ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, notes payable consisted of the following:

September 30, 2022

December 31, 2021

(in thousands)
Charitable Contributions1
$
812
$
1,238
Private placement debt dated April 30, 20212

235,519

228,690
Mortgage notes3

19,200

10,006
Total notes payable

255,531

239,934
Less: current portion of notes payable

(1,027)

(783)
Notes payable, net of current portion
$
254,504
$
239,151


		June 30, 2023		December 31, 2022
		(in thousands)
Charitable Contributions1	$	449	$	764
Private placement debt dated April 30, 20212		242,347		237,795
Mortgage notes3		47,109		37,109
Total notes payable		289,905		275,668
Less: current portion of notes payable		(1,048)		(1,037)
Notes payable, net of current portion	$	288,857	$	274,631

1 In connection with acquisitions completed in 2017 and 2019, the Company is required to make quarterly charitable contributions of $50 thousand through October 2024 and annual charitable contributions of $250 thousand throughMay 2024, respectively. The net present value of these required payments has been recorded as a liability with interest rates ranging between 2.17% ~~and~~- 7.00%.

2 The April 30, 2021 private placement debt, as amended on October 21, 2021 (the ~~"Notes~~”“April 30, 2021 Notes”) ~~was~~, were issued in ~~an original~~a total amount of $249,934 thousand with an interest rate of 7.00%, maturing on April 30, ~~2024~~2025. The April 30, 2021 Notes were issued at a discount, the carrying value of which was $~~14,415~~7,587 thousand and $~~21,244~~12,139 thousand as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively.

3 Mortgage notes ~~in the original amount~~with an initial value of $~~19,947~~48,426 thousand and $~~10,437~~38,292 thousand, ~~as of September 30, 2022 and December 31, 2021,~~ respectively, were issued by the Company in connection with various operating ~~properties. These mortgage notes~~properties, and were ~~issued~~recorded at ~~a discount, the carrying~~such gross value ~~of which,~~ as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021, was $153~~ ~~thousand and $162~~ ~~thousand, respectively, and are presented net of principal payments of $594~~ ~~thousand and $269~~ ~~thousand, respectively. The~~2022. These mortgage notes mature between August 20, 2025 and June 5, 2035.

~~(a) Extension of Maturity Date on April 30, 2021 Notes~~

On July 14, 2022, the Company exercised its right to extend the maturity date of the Notes by one year from April 30, 2024 to April 30, 2025. The extension to the maturity date did not involve any amendment to the Notes or any additional consideration to the existing lenders. with interest rates ranging between

~~(b) Construction-to-Permanent Financing Arrangement~~

OnOctober 12, 2022, the Company entered into a construction-to-permanent financing arrangement (the “Construction Loan”) which provided funding for the construction of a cultivation and processing facility in the amount of up to $~~31,000~~ ~~thousand. The Construction Loan will bear interest of U.S. prime rate plus~~ 15.00%~~, with a floor of~~ 5%, and ~~mature upon the earlier of the completion of the construction, or~~ 24 ~~months.~~ ~~Interest only payments will be due on the first of each month beginning on November 1, 2022. Upon maturity, the Construction Loan will convert to a~~ ~~10 year~~ ~~mortgage note with a fixed interest rate of~~ 3~~% over the weekly average yield of the U.S. treasury securities adjusted to a constant maturity of~~ ~~five years, with a floor of~~ 59.25%. ~~Payments~~The mortgage notes were issued at a discount, the carrying value of ~~both~~which was $259 thousand and $437 thousand, respectively, and are presented net of principal payments of $1,058 thousand and ~~interest will be due on the first day~~$746 thousand as of ~~each calendar month following conversion.~~June 30, 2023 and December 31, 2022, respectively.

~~(c)~~(b) Related Parties

A portion of the April 30, 2021 Notes are held by related parties as well as unrelated third-party lenders at a percentage of approximately 1% and 99%, respectively. The related parties consist of Benjamin Kovler, the Chairman and Chief Executive Officer of the Company (held through KP Capital, LLC and Outsiders Capital, LLC); Andrew Grossman, the Executive Vice President of Capital Markets of the Company (held through AG Funding Group, LLC); Anthony Georgiadis, the ~~Chief Financial Officer~~President and a director of the Company (held through Three One Four Holdings, LLC); and Anthony Georgiadis and William Gruver, a former director of the Company (held through ABG, LLC).

9.8. WARRANTS

As part of the financing of the ~~Company’s~~April 30, 2021 Notes, as well as other financing arrangements, the Company issued warrants to related parties, as well as unrelated third parties, which allow the holders to purchase Subordinate Voting Shares at an exercise price determined at the time of issuance.

The following table summarizes the number of warrants outstanding as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:

Liability Classified

Equity Classified

Number of Shares

Weighted Average Exercise Price (C$)

Weighted Average Remaining Contractual Life

Number of Shares

Weighted Average Exercise Price (USD)

Weighted Average
Remaining Contractual Life

Balance as of December 31, 2021

2,097,931

C$

18.26

2.42

1,737,347

$

31.83

4.38

Balance as of September 30, 2022

2,097,931

C$

18.26

1.67

1,737,347

$

31.83

3.63


	Liability Classified							Equity Classified
	Number of Shares			Weighted Average Exercise Price (C$)		Weighted Average Remaining Contractual Life		Number of Shares			Weighted Average Exercise Price (USD)		Weighted Average Remaining Contractual Life
Balance as of December 31, 2022		1,997,208	C$		18.03		1.50		1,737,347	$		31.83		3.38
Balance as of June 30, 2023		1,997,208	C$		18.03		1.01		1,737,347	$		31.83		2.88

(a) Liability Classified Warrants Outstanding

The following table summarizes the fair value of the liability classified warrants at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:


				Fair Value										Fair Value
Warrant Liability	Strike Price	Warrants Outstanding		September 30, 2022		December 31, 2021		Change			Strike Price	Warrants Outstanding		June 30, 2023		December 31, 2022		Change
				(in thousands)										(in thousands)
Bridge Financing Warrants Issued April 2019	C$22.90		100,723	$	-	$	676	$	(676	)
Private Placement Financing Warrants Issued May 2019	C$19.39		1,606,533		3,413		18,527		(15,114	)	C$19.39		1,606,533	$	1,414	$	3,125	$	(1,711	)
Modification Warrants Issued November 2019	C$12.04		316,947		1,278		4,603		(3,325	)	C$12.04		316,947		668		1,139		(471	)
Additional Modification Warrants Issued May 2020	C$14.03		73,728		310		1,071		(761	)	C$14.03		73,728		175		256		(81	)
Totals			2,097,931	$	5,001	$	24,877	$	(19,876	)			1,997,208	$	2,257	$	4,520	$	(2,263	)

During the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, the Company recorded ~~a loss~~gains of $~~1,896~~ ~~thousand and a gain of $19,876~~ ~~thousand, and a gain of $13,462~~621 thousand and $~~5,451~~2,263 thousand, and $13,843 thousand and $21,772 thousand, respectively, on the change in the fair value of the warrant liability within other income ~~(expense)~~ on the unaudited interim condensed consolidated statements of operations. As of June 30, 2023, the warrant liability was classified as a current liability, and recorded within accrued liabilities on the unaudited interim condensed consolidated balance sheet.

The following table summarizes the significant assumptions used in determining the fair value of the warrant liability as of each reporting ~~date:~~

September 30,

December 31,
Significant Assumptions
2022

2021
Volatility
62.67% - 73.55%

59.95% - 74.04%
Remaining Term
0.03 - 2.65 years

0.78 - 3.39 years
Risk Free Rate
3.72% - 3.76%

0.91% - 1.06%

~~See~~date (see Note 1413 - Fair Value Measurements for additional ~~details.~~details):


	June 30,	December 31,
Significant Assumptions	2023	2022
Volatility	71.66% - 76.66%	70.44% - 78.21%
Remaining Term	0.9 - 1.9 years	1.39 - 2.39 years
Risk Free Rate	4.54%	3.82% - 4.07%

~~10.~~9. SHARE CAPITAL

Common shares, which include the Company’s Subordinate Voting Shares, Multiple Voting Shares and Super Voting Shares, are classified as equity. Incremental costs directly attributable to the issuance of common shares are recognized as a deduction from equity. The proceeds from the exercise of stock options or warrants together with amounts previously recorded in reserves over the applicable vesting periods are recorded as share capital. Income tax relating to transaction costs of an equity transaction is accounted for in accordance with Accounting Standards Codification (“ASC”) 740, Income Taxes.

(a) Authorized

The Company has the following classes of share capital, with each class having no par value:

(i) Subordinate Voting Shares

The holders of the Subordinate Voting Shares are entitled to receive dividends which may be declared from time to time and are entitled to one vote per share at meetings of the Company’s shareholders. All Subordinate Voting Shares are ranked equally with regard to the Company’s residual assets. The Company is authorized to issue an unlimited number of no par value Subordinate Voting Shares. ~~During the nine months ended September 30, 2022, the shareholders of the Company converted~~ ~~33,341~~ ~~Multiple Voting Shares into~~ ~~3,334,100~~ ~~Subordinate Voting Shares.~~

(ii) Multiple Voting Shares

Each Multiple Voting Share is entitled to 100 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares. At ~~September~~June 30, ~~2022,~~2023, the Company had 38,531 issued and outstanding Multiple Voting Shares, which convert into 3,853,100 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Multiple ~~Voting Shares. During the nine months ended September 30, 2022, the shareholders of the Company converted~~ ~~33,341~~ ~~Super Voting Shares into~~ ~~33,341~~ ~~Multiple Voting Shares and~~ ~~33,341~~ ~~Multiple Voting Shares into~~ ~~3,334,100~~ ~~Subordinate~~ Voting Shares.

(iii) Super Voting Shares

Each Super Voting Share is entitled to 1,000 votes per share at shareholder meetings of the Company and is exchangeable for 100 Subordinate Voting Shares or one Multiple Voting Share. At ~~September~~June 30, ~~2022,~~2023, the Company had 251,690 issued and outstanding Super Voting Shares which convert into 25,169,000 Subordinate Voting Shares. The Company is authorized to issue an unlimited number of Super Voting Shares. ~~During the nine months ended September 30, 2022, the shareholders of the Company converted~~ ~~33,341~~ ~~Super Voting Shares into~~ ~~33,341~~ ~~Multiple Voting Shares.~~

(b) Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

Issued and Outstanding

Subordinate
Voting
Shares

Multiple
Voting
Shares

Super
Voting
Shares
As at January 1, 2022

201,768,312

38,531

285,031
Issuance of shares under business combinations and investments

204,036

—

—
Distribution of contingent consideration

667,080

—

—
Issuance of shares upon exercise of options and warrants

311,535

—

—
Issuances of shares upon vesting of RSUs

388,273

—

—
Shares issued for settlement of business obligation

80,588

—

—
Exchange of shares

3,334,100

—

(33,341)
As at September 30, 2022

206,753,924

38,531

251,690


	Issued and Outstanding
	Subordinate Voting Shares	Multiple Voting Shares	Super Voting Shares
As at January 1, 2023	206,991,275	38,531	251,690
Distribution of contingent consideration	822,447	—	—
Distribution of deferred shares	680,089	—	—
Issuance of shares upon exercise of options	130,508	—	—
Issuances of shares upon vesting of RSUs	351,721	—	—
As at June 30, 2023	208,976,040	38,531	251,690

Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

(i)~~Issuance~~ Distribution of Deferred Shares ~~Under Business Combinations and Investments~~

~~ILDISP, LLC~~As part of the consideration exchanged for certain acquisitions completed throughout 2021, the Company deferred the distribution of Subordinate Voting Shares to secure the Company's indemnification rights associated with post-acquisition costs. The following table summarizes the activity during the six months ended June 30, 2023:

~~On March 1,~~As of June 30, 2023 and December 31, 2022, the Company ~~issued~~ ~~204,036~~ ~~Subordinate Voting Shares with a value~~held deferred shares in the amount of ~~approximately~~ $~~3,785~~12,973 thousand ~~based on a~~ and $2036,211 ~~consecutive day volume weighted average price (“VWAP”), in connection~~thousand, respectively. In accordance with the ~~Company's~~relevant acquisition agreement, a portion of the ~~remaining ownership interests~~outstanding deferred shares were cancelled in ~~two Illinois-based retail stores. The~~order to indemnify the Company for post-acquisition costs. As the cancellation of the deferred shares ~~issued resulted in~~occurred outside of the measurement period, rather than an ~~increase in~~adjustment to the ~~Company's share capital~~purchase price allocation, the Company recorded a gain of $2,784 thousand during the three and ~~a corresponding increase in~~six months ended June 30, 2023. For the ~~net assets acquired. See Note 4 - Acquisitions for additional details.~~three and six months ended June 30, 2022, no such cancellations occurred.

In connection with the Company's 2021 acquisition of Dharma Pharmaceuticals, LLC (“Dharma”), the purchase agreement included contingent consideration of up to $65,000 thousand in Subordinate Voting Shares of Green Thumb, dependent upon the successful opening of up to five retail stores in the Virginia area within the first three years following the signing of the agreement and the legal sale of ~~adult use~~adult-use cannabis in a ~~Retail dispensary~~retail store by January 1, 2025. On ~~February 25, 2022,~~June 1, 2023, the Company issued ~~667,080~~822,447 Subordinate Voting Shares to the former owners of Dharma in connection with the successful opening of ~~two Retail stores~~the fourth retail store in Virginia. The shares had a fair value of $~~13,111~~6,070 thousand at the date of issuance.

~~As of September 30, 2022 and December 31, 2021,~~ On June 28, 2023, the ~~estimated fair value of~~Company successfully opened a fifth retail store in Virginia. However, the ~~contingent consideration~~shares associated with this achievement were not issued until July 2023. As the ~~acquisition~~liability was no longer contingent upon a future event, the Company recorded an obligation of ~~Dharma, which was valued based on a probability weighting of the potential payments, was~~ $~~41,038~~6,000 thousand, ~~and $48,665~~ ~~thousand, respectively. As of September 30, 2022 and December 31, 2021, $11,210~~ ~~thousand and $20,884~~ ~~thousand, respectively, was included as a current liability~~within accrued liabilities on the Company's unaudited interim condensed consolidated balance ~~sheets.~~sheets representing the fair value of the Subordinate Voting Shares to be issued.

The Company operates equity settled stock-based remuneration plans for its eligible directors, officers, employees and consultants. All goods and services received in exchange for the grant of any stock-based payments are measured at their fair value unless the fair value cannot be estimated reliably. If the Company cannot estimate reliably the fair value of the goods and services received, the Company measures their value indirectly by reference to the fair value of the equity instruments granted. For transactions with employees and others providing similar services, the Company measures the fair value of the services by reference to the fair value of the equity instruments granted. Equity settled stock-based payments under stock-based payment plans are ultimately recognized as an expense in profit or loss with a corresponding credit to equity.

In June 2018, the Company established the Green Thumb Industries Inc. 2018 Stock and Incentive Plan, which was amended by Amendment No. 1 and Amendment No. 2 thereto (as amended, the “Plan”). The maximum number of ~~shares that may be~~Restricted Stock Units (“RSUs”) and options issued under the Plan shall not exceed 10% of the issued and outstanding shares on an as-converted basis.

The Company recognizes compensation expense for ~~Restricted Stock Units (“RSUs”)~~RSUs and options on a straight-line basis over the requisite service period of the award. Non-market vesting conditions are included in the assumptions about the number of options that are expected to become exercisable. Estimates are subsequently revised if there is any indication that the number of share options expected to vest differs from the previous estimate. Any cumulative adjustment prior to vesting is recognized in the current period with no adjustment to prior periods for expense previously recognized.

~~The Company's option~~Option and RSU awards generally vest over three years, and options typically have a life of five to ten years. Option ~~and RSU~~ grants are determined by the Compensation Committee of the Company’s Board of Directors with the option price set at no less than 100% of the fair market value of a share on the date of grant.

As permitted under ASC 718, the Company has made an accounting policy choice to account for forfeitures when they occur.

As of June 30, 2023, $51,798 thousand of total unrecognized expense related to stock-based compensation awards is expected to be recognized over a weighted-average period of 2.20 years.

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the applicable measurement date and the exercise price of such options, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options on September 30, 2022 and December 31, 2021. This amount will change in future periods based on the fair market value of the Company’s Subordinate Voting Shares and the number of options outstanding.

~~As permitted under ASC 718, the Company has made an accounting policy choice to account for forfeitures when they occur.~~

~~As of September 30, 2022, $46,205~~ ~~thousand of total unrecognized expense related to stock-based compensation awards is expected to be recognized over a weighted-average period of~~ ~~2.06~~ ~~years.~~

~~12.~~11. OTHER INCOME (EXPENSE)

For the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 other income (expense) was comprised of the following:


		Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended June 30,				Six Months Ended June 30,
		2022		2021		2022		2021		2023		2022		2023		2022
		(in thousands)				(in thousands)				(in thousands)				(in thousands)
Fair value adjustments on equity investments	$	247	$	(4,075)	$	(17,368)	$	14,604	$	(655)	$	(8,018)	$	(1,134)	$	(17,627)
Fair value adjustments on equity method investments		—		—		14,119		—		—		—		—		14,119
Loss on extinguishment of debt		—		—		—		(9,882)
Fair value adjustments on warrants issued		(1,896)		13,462		19,876		5,451		621		13,843		2,263		21,772
Earnings (loss) from equity method investments		(441)		(316)		(2,382)		1,330		(432)		(738)		(750)		(1,941)
Other		5		(946)		688		(1,698)		196		496		275		695
Total Other Income (Expense)	$	(2,085)	$	8,125	$	14,933	$	9,805	$	(270)	$	5,583	$	654	$	17,018

~~14.~~13. FAIR VALUE MEASUREMENTS

The Company applies fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities that are required to be recorded at fair value, the Company considers all related factors of the asset by market participants in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions, and credit risk.

The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; and

Level 3 – Inputs for the asset or liability that are not based on observable market data.

(a) Financial Instruments

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, investments, accounts payable and accrued liabilities, notes payable, warrant liability, and contingent consideration payable.

~~For~~It was not practicable to estimate the fair value of the Company's long-term notes payable, ~~(which~~which consist of charitable contributions, private placement debt and mortgage ~~notes), for which~~notes, since there were no quoted ~~market~~ prices or active trading ~~markets, it was not practicable to estimate the fair value of these financial instruments.~~markets. The carrying amount of notes payable at ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was $~~255,531~~289,905 thousand and $~~239,934~~275,668 thousand, ~~respectively,~~ which includes $~~1,027~~1,048 thousand and $~~783~~1,037 thousand, respectively, of short-term debt due within one year.

Financial instruments recorded at fair value are classified using a fair value hierarchy that reflects the significance of the inputs to fair value measurements.The fair values of the Company’s financial instruments associated with each of the three levels of the hierarchy are:


		As of September 30, 2022								As of June 30, 2023
	(in thousands)								(in thousands)
		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	147,258	$	—	$	—	$	147,258	$	149,026	$	—	$	—	$	149,026
Investments		26,235		—		53,746		79,981		23,584		—		51,476		75,060
Contingent Consideration Payable		—		—		(41,950)		(41,950)		—		—		(32,022)		(32,022)
Warrant Liability		—		—		(5,001)		(5,001)		—		—		(2,257)		(2,257)
	$	173,493	$	—	$	6,795	$	180,288	$	172,610	$	—	$	17,197	$	189,807


		As of December 31, 2022
	(in thousands)
		Level 1		Level 2		Level 3		Total
Cash and Cash Equivalents	$	177,682	$	—	$	—	$	177,682
Investments		24,749		—		49,420		74,169
Contingent Consideration Payable		—		—		(41,943)		(41,943)
Warrant Liability		—		—		(4,520)		(4,520)
	$	202,431	$	—	$	2,957	$	205,388

The Company remeasured its contingent consideration arrangements associated with its 2021 acquisitions of Mobley Pain Management and Wellness Center LLC and Canwell Processing LLC (collectively “Summit”) and GreenStar Herbals Inc. (“GreenStar”) using Monte Carlo simulation models. During the three and nine months ended September 30, 2022, the remeasurement resulted in a net (loss)/gain of $(~~191) thousand and $34,289~~ thousand, respectively. The change in the fair value of the contingent consideration was driven by a change in management's estimates and projections of the acquired entities' ability to achieve the performance targets as agreed to in the 2021 acquisition agreements along with the change in fair value of the shares to be issued.

The amount was recorded, net, within selling, general, and administrative expenses on the unaudited interim condensed consolidated statement of operations. Significant assumptions used in the Company's September 30, 2022 remeasurement include Green Thumb's stock price as of September 30, 2022 and projected earnings metrics and revenue targets as of such period then ended.

~~15. VARIABLE INTEREST ENTITIES~~

The following table presents the summarized financial information about the Company’s consolidated variable interest entities (“VIEs”) which are included in the unaudited interim condensed consolidated balance sheet as of September 30, 2022 and the consolidated balance sheet as of December 31, 2021. All of these entities were determined to be VIEs as the Company possesses the power to direct activities through management services agreements (“MSAs”):

ILDISP,
LLC

Other
Non-material VIEs

ILDISP,
LLC

Other
Non-material VIEs

September 30, 2022

December 31, 2021

(in thousands)

(in thousands)
Current assets
$
                               —
$
648

$
4,118
$
1,033
Non-current assets

—

1,974

3,290

1,761
Current liabilities

—

419

10,719

854
Non-current liabilities

—

622

413

696
Noncontrolling interests

—

279

                           (1,862)

224
Equity attributable to Green Thumb Industries Inc.

—

1,302

                           (1,862)

1,020

~~On March 1, 2022, the Company acquired the remaining~~ 50~~% minority interest in ILDISP, for $11,857~~ ~~thousand in cash and the issuance of~~ ~~128,218~~ ~~shares of Green Thumb, which had a fair value of $2,379~~ thousand. As a result, the remaining equity associated with the noncontrolling interest was closed to accumulated surplus (deficit) of Green Thumb as of March 1, 2022. See Note 4 - Acquisitions for additional details.

~~Green Thumb Industries Inc.~~

~~Notes to Unaudited Interim Condensed Consolidated Financial Statements~~

~~(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)~~

~~15. VARIABLE INTEREST ENTITIES~~ ~~(Continued)~~

The following tables present the summarized financial information about the Company’s VIEs which are included in the unaudited interim condensed consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021:

Three Months Ended

September 30, 2022

September 30, 2021

ILDISP,
LLC

Other
Non-material VIEs

ILDISP,
LLC

Other
Non-material VIEs

(in thousands)

(in thousands)
Revenues, Net of Discounts
$
—
$
2,306

$
6,331
$
3,981
Net income attributable to noncontrolling interests

—

319

1,017

359
Net income attributable to Green Thumb Industries Inc.

—

269

1,017

713
Net income
$
—
$
588

$
2,034
$
1,072

Nine Months Ended

September 30, 2022

September 30, 2021

ILDISP,
LLC

Other
Non-material VIEs

ILDISP,
LLC

Other
Non-material VIEs

(in thousands)

(in thousands)
Revenues, Net of Discounts
$
3,543
$
6,805

$
18,275
$
11,115
Net income attributable to noncontrolling interests

462

898

2,658

1,027
Net income attributable to Green Thumb Industries Inc.

462

761

2,658

1,602
Net income
$
924
$
1,659

$
5,316
$
2,629

As of September 30, 2022 and December 31, 2021, the VIE included in the Other Non-material VIEs is Bluepoint Wellness of Westport, LLC. As of September 30, 2021, VIEs included in the Other Non-material VIEs are Bluepoint Wellness of Westport, LLC and Meshow, LLC.

~~16.~~14. SEGMENT REPORTING

The Company operates in two segments: the cultivation, production and sale of cannabis products to ~~Retail~~retail stores (“Consumer Packaged Goods”) and retailing of cannabis to patients and consumers (“Retail”). The Company does not allocate operating expenses to these ~~segments,~~business units, nor does it allocate specific assets. Additionally, the Chief Operating Decision Maker does not review total assets or net income (loss) by segments; therefore, such information is not presented below.

The below table presents ~~segment information~~revenues by type for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:

Three Months Ended September 30,

Nine Months Ended September 30,

2022

2021

2022

2021

(in thousands)

(in thousands)
Revenues, Net of Discounts

Retail
$
199,632
$
161,016

$
564,951
$
441,241
Consumer Packaged Goods

127,676

121,074

368,692

343,014
Intersegment Eliminations

                 (66,114)

                 (48,413)

                (175,538)

             (134,276)
Total Revenues, Net of Discounts
$
261,194
$
233,677

$
758,105
$
649,979
Depreciation and Amortization

Retail
$
9,921
$
8,041

$
29,881
$
21,693
Consumer Packaged Goods

14,597

9,132

41,825

25,546
Intersegment Eliminations

—

—

—

—
Total Depreciation and Amortization
$
24,518
$
17,173

$
71,706
$
47,239
Income Taxes

Retail
$
18,589
$
21,302

$
58,460
$
55,251
Consumer Packaged Goods

14,380

16,018

43,980

42,952
Intersegment Eliminations

—

—

—

—
Total Income Taxes
$
32,969
$
37,320

$
102,440
$
98,203


		Three Months Ended June 30,				Six Months Ended June 30,
		2023		2022		2023		2022
		(in thousands)				(in thousands)
Revenues, Net of Discounts
Retail	$	188,044	$	192,734	$	376,922	$	365,320
Consumer Packaged Goods		136,054		120,604		261,671		241,016
Intersegment Eliminations		(71,710)		(59,027)		(137,669)		(109,425)
Total Revenues, Net of Discounts	$	252,388	$	254,311	$	500,924	$	496,911
Depreciation and Amortization
Retail	$	9,109	$	10,127	$	17,941	$	19,960
Consumer Packaged Goods		15,125		14,071		29,794		27,228
Intersegment Eliminations		—		—		—		—
Total Depreciation and Amortization	$	24,234	$	24,198	$	47,735	$	47,188
Income Taxes
Retail	$	13,328	$	21,681	$	32,339	$	39,871
Consumer Packaged Goods		12,437		16,659		27,062		29,600
Intersegment Eliminations		—		—		—		—
Total Income Taxes	$	25,765	$	38,340	$	59,401	$	69,471

Goodwill assigned to the Consumer Packaged Goods segment as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was $~~358,280~~315,889 thousand and $~~358,038~~315,889 thousand, respectively. Intangible assets, net assigned to the Consumer Packaged Goods segment as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was $~~297,160~~273,581 thousand and $~~317,454~~286,922 thousand, respectively.

Goodwill assigned to the Retail segment as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was $~~286,305~~273,802 thousand and $~~274,811~~273,802 thousand, respectively. Intangible assets, net assigned to the Retail segment as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was $~~343,828~~290,584 thousand and $~~358,037~~302,597 thousand, respectively.

The Company’s assets are aggregated into two reportable segments (Retail and Consumer Packaged Goods). For the purposes of testing goodwill, Green Thumb has identified ~~30 reporting units. The Company determined its~~two reporting units ~~by first reviewing the operating~~which align with our reportable segments ~~based on the geographic areas in which Green Thumb conducts business (or each market). The markets were then further divided into reporting units based on the market operations~~ (Retail and Consumer Packaged Goods) ~~which were primarily determined based on the licenses each market holds.~~. All revenues are derived from ~~sales occurring~~customers domiciled in the United States and all assets are located in the United States.

ITEM 2. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

This management discussion and analysis (“MD&A”) of the financial condition and results of operations of Green Thumb Industries Inc. (the “Company”, or “Green Thumb”~~, “we” or “us”~~) is for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021.~~2022. It is supplemental to, and should be read in conjunction with, the Company’s unaudited interim condensed consolidated financial statements as of ~~September~~June 30, ~~2022~~2023 and the consolidated financial statements for the year ended December 31, ~~2021~~2022 included in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 filed with the U.S. Securities and Exchange Commission on March 1, ~~2022~~2023 (the ~~“2021~~“2022 Form 10-K”) and the accompanying notes for each respective period. The Company’s financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Financial information presented in this MD&A is presented in United States dollars (“$” or “US$”), unless otherwise indicated.

This MD&A contains certain “forward-looking statements” and certain “forward-looking information” as defined under applicable United States securities laws. Please refer to the discussion of forward-looking statements and information set out under the heading “Disclosure Regarding Forward-Looking Statements,” identified in the ‘‘Risks and Uncertainties’’ section of this MD&A and in Part II, Item 1A, “Risk ~~Factors”~~Factors of the ~~2021~~2022 Form 10-K.” As a result of many factors, the Company’s actual results may differ materially from those anticipated in these forward-looking statements and information.

In March 2020, the World Health Organization categorized coronavirus disease 2019 (together with its variants “COVID-19”) as a pandemic. COVID-19 continues to spread throughout the U.S. and other countries across the world, and the duration, and severity of its effects are currently unknown. The Company continues to implement and evaluate actions to strengthen its financial position and support the continuity of its business and operations in the face of this pandemic and other events.

The Company’s priority during the COVID-19 pandemic is protecting the health and safety of its employees and its customers, following the recommended actions of government and health authorities. In the future, the pandemic may cause reduced demand for the Company’s products and services if, for example, the pandemic results in a recessionary economic environment or potential new restrictions on business operations or the movement of individuals.

During the first nine months of 2022, the Company’s revenue, gross profit and operating income were not negatively impacted by COVID-19 and the Company generally maintained the consistency of its operations. However, the effects of COVID-19 may impact its business operations for reasons including the potential quarantine of Green Thumb employees or those of its supply chain partners.

Established in 2014 and headquartered in Chicago, Illinois, Green Thumb ~~a national cannabis consumer packaged goods company and retailer,~~ promotes well-being through the power of cannabis through branded consumer packaged goods and people-first retail experiences, while ~~being committed~~giving back to ~~community and sustainable profitable growth.~~the communities in which it serves. As of ~~September~~June 30, ~~2022,~~2023, Green Thumb has operations in 15fifteen U.S. markets, employs approximately ~~3,800~~4,300 people and serves ~~hundreds of thousands~~millions of patients and customers annually.

Green Thumb’s core business is manufacturing, distributing and marketing a portfolio of owned cannabis consumer packaged goods brands (which we refer to as our Consumer Packaged Goods business), including &Shine, Beboe, Dogwalkers, ~~Dr.~~Doctor Solomon’s, Good Green, incredibles and RYTHM. The Company distributes and markets these products primarily to third-party licensed retail cannabis stores across the United States as well as to Green Thumb-owned ~~Retail~~retail stores (which we refer to as our Retail business).

The Company’s Consumer Packaged Goods portfolio is primarily generated from plant material that Green Thumb grows and processes itself, which we use to produce our consumer packaged goods in 17eighteen manufacturing facilities. This portfolio consists of stock keeping units ~~(“SKUs”)~~ across a range of ~~our Consumer Packaged Goods products,~~cannabis product categories, including flower, pre-rolls, concentrates, vape, capsules, tinctures, edibles, topicals and other cannabis-related products (none of which product categories are individually material to the Company). These Consumer Packaged Goods products are sold in ~~Retail locations~~retail stores throughout the U.S. including at Green ~~Thumb's~~Thumb’s own RISE and other ~~Retail~~ stores.

Green Thumb owns and operates a national cannabis retail chain called RISE~~which are~~ that provides relationship-centric retail experiences aimed to deliver a superior level of customer service through high-engagement consumer interaction, a consultative, transparent and education-forward selling approach and a consistently available assortment of cannabis products. In addition, Green Thumb owns ~~Retail~~ stores under other names, primarily where naming is subject to licensing or similar ~~restrictions.~~restrictions or in certain instances where we co-own the store. The income from Green Thumb’s ~~Retail~~retail stores is primarily derived from the sale of cannabis-related products, which includes the sale of Green Thumb produced products as well as those produced by third parties, with an immaterial (under 10%) portion of this income resulting from the sale of other merchandise (such as t-shirts and accessories for cannabis use). The RISE stores currently are ~~currently~~ located in ~~ten~~fourteen of the states in which we operate. As of ~~September~~June 30, ~~2022,~~2023, the Company had 7783 open and operating ~~Retail locations.~~retail stores. The Company’s new store opening plans will remain fluid depending on market conditions, obtaining local licensing, construction and other permissions and ~~are~~ subject to the Company’s capital allocation ~~plans and the evolving situation with respect to COVID-19.~~plans.

The following table sets forth the Company’s selected consolidated financial results for the periods, and as of the dates, indicated. The (i) unaudited interim condensed consolidated statements of operations for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022 and (ii) unaudited interim condensed consolidated balance sheet as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 have been derived from, and should be read in conjunction with, the unaudited interim condensed consolidated financial statements and accompanying notes presented in ~~Part I,~~ Item 1 of this ~~Report.~~quarterly report on Form 10-Q.

The Company’s unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP and on a going-concern basis that contemplates continuity of operations and realization of assets and liquidation of liabilities in the ordinary course of business.


		Three Months Ended September 30,				Nine Months Ended September 30,				QTD Change			YTD Change			Three Months Ended June 30,				Six Months Ended June 30,				QTD Change			YTD Change
		2022		2021		2022		2021		$	%		$	%		2023		2022		2023		2022		$	%		$	%
		(in thousands, except share and per share amounts)														(in thousands, except share and per share amounts)								Increase (Decrease)
Revenues, Net of Discounts	$	261,194	$	233,677	$	758,105	$	649,979	$	27,517	12%	$	108,126	17%	$	252,388	$	254,311	$	500,924	$	496,911	$	(1,923)	(1)%	$	4,013	1%
Cost of Goods Sold, Net		(129,954)		(104,159)		(378,127)		(286,685)		(25,795)	(25)%		(91,442)	32%		(127,108)		(128,513)		(250,923)		(248,173)		(1,405)	(1)%		2,750	1%
Gross Profit		131,240		129,518		379,978		363,294		1,722	1%		16,684	5%		125,280		125,798		250,001		248,738		(518)	(0)%		1,263	1%
Expenses:
Selling, General, and Administrative																84,217		63,535		164,736		131,923		20,682	33%		32,813	25%
Total Expenses		82,479		71,449		214,402		202,836		11,030	15%		11,566	6%		84,217		63,535		164,736		131,923		20,682	33%		32,813	25%
Income From Operations		48,761		58,069		165,576		160,458		(9,308)	(16)%		5,118	3%		41,063		62,263		85,265		116,815		(21,200)	(34)%		(31,550)	(27)%
Total Other Income (Expense)		(5,644)		837		1,429		(5,940)		(6,481)	(774)%		7,369	124%		(1,608)		808		(2,769)		7,073		(2,416)	(299)%		(9,842)	(139)%
Income Before Provision for Income Taxes And Non-Controlling Interest		43,117		58,906		167,005		154,518		(15,789)	(27)%		12,487	8%		39,455		63,071		82,496		123,888		(23,616)	(37)%		(41,392)	(33)%
Provision for Income Taxes		32,969		37,320		102,440		98,203		(4,351)	(12)%		4,237	4%		25,765		38,340		59,401		69,471		(12,575)	(33)%		(10,070)	(14)%
Net Income Before Non-Controlling Interest		10,148		21,586		64,565		56,315		(11,438)	(53)%		8,250	15%		13,690		24,731		23,095		54,417		(11,041)	(45)%		(31,322)	(58)%
Net Income Attributable to Non-Controlling Interest		319		1,376		1,360		3,685		(1,057)	(77)%		(2,325)	(63)%		290		294		556		1,041		(4)	(1)%		(485)	(47)%
Net Income Attributable To Green Thumb Industries Inc.	$	9,829	$	20,210	$	63,205	$	52,630	$	(10,381)	(51)%	$	10,575	20%	$	13,400	$	24,437	$	22,539	$	53,376	$	(11,037)	(45)%	$	(30,837)	(58)%
Net Income Per Share - Basic	$	0.04	$	0.09	$	0.27	$	0.24	$	(0.05)	(56)%	$	0.03	13%	$	0.05	$	0.11	$	0.09	$	0.23	$	(0.06)	(55)%	$	(0.14)	(61)%
Net Income Per Share - Diluted	$	0.04	$	0.08	$	0.26	$	0.23	$	(0.0)	(50)%	$	0.03	13%	$	0.05	$	0.10	$	0.09	$	0.22	$	(0.05)	(50)%	$	(0.13)	(59)%
Weighted Average Number of Shares Outstanding – Basic		237,002,873		226,529,671		236,546,078		221,059,870								238,000,135		236,783,625		237,700,856		236,313,896
Weighted Average Number of Shares Outstanding – Diluted		237,804,799		230,879,437		237,872,595		225,411,773								238,423,288		237,762,903		239,455,964		237,869,300


		September 30, 2022		December 31, 2021		June 30, 2023		December 31, 2022
		(in thousands)				(in thousands)
Total Assets	$	2,455,880	$	2,385,851	$	2,512,834	$	2,433,528
Long-Term Liabilities	$	619,634	$	561,994	$	631,757	$	621,525

Three Months Ended ~~September~~June 30, ~~2022~~2023 Compared to the Three Months Ended ~~September~~June 30, ~~2021~~2022

Revenue for the three months ended ~~September~~June 30, ~~2022~~2023 was ~~$261,194~~$252,388 thousand, ~~up 12%~~a decrease of 1% from ~~$233,677~~$254,311 thousand for the three months ended ~~September~~June 30, ~~2021, driven~~2022. The Company increased the number of total units sold, but due to price compression, total revenue declined. This decrease was partially offset by ~~contributions from both Retail and Consumer Packaged Goods. Key performance drivers for the Retail business for the quarter were: legalization of adult use sales~~continued growth in existing markets such as New Jersey, ~~which began on April 21, 2022,~~Virginia, and Connecticut, as well as revenue generated from new ~~store openings including acquired Retail~~retail stores ~~particularly~~opened in ~~Illinois, Maryland, Massachusetts, Minnesota, Rhode Island and Virginia and increased store traffic to Green Thumb’s open and operating Retail stores, particularly in Illinois.~~ the current period.

The Company generated revenue from ~~77 Retail locations~~83 retail stores during the quarter, compared to 6577 in the same quarter of the prior year. ~~Since September~~During the three months ended June 30, ~~2021,~~2023, the Company ~~acquired~~opened two retail stores in Pennsylvania, two retail stores in Virginia, one ~~Retail~~retail store ~~in Illinois, one in Maryland, five~~ in Minnesota, and ~~opened five new Retail stores~~one retail store in ~~Massachusetts, Nevada, Virginia and Minnesota that contributed to the increase in Retail revenues.~~Nevada.

The key drivers for the increase in Consumer Packaged Goods revenues was increased sales in New Jersey due to legalization of adult use sales, which began on April 21, 2022, and growth in Illinois. In addition, the Company also acquired one cultivation and processing facility in Minnesota since September 30, 2021.

Cost of goods sold are derived from ~~Retail~~retail purchases made by the Company from its third-party licensed producers operating within our state markets and costs related to the internal cultivation and production of cannabis. Cost of goods sold for the three months ended ~~September~~June 30, ~~2022~~2023 was ~~$129,954~~$127,108 thousand, ~~up 25%~~a decrease of 1% from ~~$104,159~~$128,513 thousand for the three months ended ~~September~~June 30, ~~2021,~~2022, driven by ~~increased volume from open and operating Retail stores, new and acquired Retail store openings~~the decrease in ~~Illinois, Maryland, Massachusetts, Minnesota, Nevada and Virginia, and expansion of the consumer products sales primarily in Illinois and New Jersey~~revenue as described above.

Gross profit for the three months ended ~~September~~June 30, ~~2022~~2023 was ~~$131,240~~$125,280 thousand, representing a gross margin on the sale of branded cannabis flower and processed and packaged products including concentrates, edibles, topicals and other cannabis products, of 50%. This is compared to gross profit for the three months ended ~~September~~June 30, ~~2021~~2022 of ~~$129,518~~$125,798 thousand, or a ~~55%~~49% gross margin. The increase in gross margin (percent) was primarily driven by increased sales of Company branded products which have higher margins. The decrease in gross profit (dollars) was directly attributable to the revenue ~~increase~~decrease as described above.

Total expenses for the three months ended ~~September~~June 30, ~~2022~~2023 were ~~$82,479~~$84,217 thousand, or ~~32%~~33% of revenues, net of discounts, resulting in aan increase of ~~$11,030~~$20,682 thousand over the same period in the prior year. Total expenses for the three months ended ~~September~~June 30, ~~2021~~2022 were ~~$71,449~~$63,535 thousand or ~~31%~~25% of revenues, net of discounts. ~~The increase~~Total expenses were lower in ~~total expenses was attributable~~the three months ended June 30, 2022 primarily due to ~~Retail salaries and benefits, depreciation expense and other operational and facility expenses mainly as a result of~~favorable fair value adjustments associated with the Company’s addition of five new and seven acquired Retail stores over the prior year period. In addition, an increase in intangible amortization expense and corporate staff salaries also contributed to the overall increase in total expenses.Company's contingent consideration arrangements.

Total other income (expense) for ~~the~~ three months ended ~~September~~June 30, ~~2022~~2023 was ~~$(5,644)~~$(1,608) thousand, a ~~change~~decrease of ~~$(6,481)~~$2,416 thousand, ~~primarily~~ due to favorable fair value adjustments to the Company's warrant liability, partially offset by unfavorable fair value adjustments associated with the Company's ~~warrant liability offset by a reduction in interest expense associated with the Company's contingent consideration arrangements~~equity investments, both recorded during the three months ended ~~September~~June 30, 2022.

Income before provision for income taxes and non-controlling interest for the three months ended ~~September~~June 30, ~~2022~~2023 was ~~$43,117~~$39,455 thousand, ana decrease of ~~$(15,789)~~$23,616 thousand compared to the three months ended ~~September~~June 30, ~~2021.~~2022.

As presented under the heading “Non-GAAP Measures” below, after adjusting for non-cash equity incentive compensation of ~~$7,878~~$7,381 thousand and ~~$4,995~~$6,833 thousand in the three months ended June 30, 2023 and 2022, respectively, and other nonoperating (income) expenses, of ~~$3,306~~$3,138 thousand and ~~$944~~$(14,557) thousand in the three months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively, adjusted ~~operating~~ earnings before interest, depreciation, and amortization (“EBITDA”) was ~~$84,463~~$75,816 thousand and ~~$81,181~~$78,737 thousand, ~~in the three months ended September 30, 2022 and 2021,~~ respectively.

Income tax expense is recognized based on the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end. For the three months ended ~~September~~June 30, ~~2022,~~2023, federal and state income tax expense totaled ~~$32,969~~$25,765 thousand compared to expense of ~~$37,320~~$38,340 thousand for the three months ended ~~September~~June 30, ~~2021.~~2022.

Net income attributable to the Green Thumb Industries for the three months ended September 30, 2022 was $9,829 thousand or $0.04 per basic and diluted share, compared to a net income of $20,210 thousand, or $0.09 per basic and $0.08 per diluted share in the same period in the prior year. The reduction in net income of $10,381 thousand was primarily due to favorable fair value adjustments to the Company’s warrant liability as reflected within other income (expense), net during the comparable period in the prior year.

~~Nine~~Six Months Ended ~~September~~June 30, ~~2022~~2023 Compared to the ~~Nine~~Six Months Ended ~~September~~June 30, ~~2021~~2022

Revenue for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 was ~~$758,105~~$500,924 thousand, ~~up 17%~~an increase of 1% from ~~$649,979~~$496,911 for the ~~nine~~six months ended ~~September~~June 30, ~~2021, driven by contributions from both Retail and Consumer Packaged Goods~~2022. The increase in revenue was largely due to legalization of ~~adult use~~adult-use sales in New Jersey, which began on April 21, 2022, continued growth in ~~Illinois,~~existing markets such as Connecticut and Virginia, as well as revenue generated from new ~~and acquired store openings, particularly~~retail stores opened in ~~Maryland, Massachusetts, Minnesota, Rhode Island and Virginia.~~ the current period, partially offset by price compression.

The Company generated revenue from ~~77 Retail locations~~83 retail stores during the period compared to 6577 in the same period of the prior year. During the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the Company opened ~~three new Retail stores. Since September 30, 2021, the Company acquired~~two retail stores in Pennsylvania, two retail stores in Virginia, one ~~Retail~~retail store ~~in Illinois, one in Maryland, five~~ in Minnesota, and ~~opened five new Retail stores~~one retail store in ~~Massachusetts, Nevada, Virginia and Minnesota that contributed to the increase in Retail revenues.~~Nevada.

The key drivers for the increase in Consumer Packaged Goods revenues was increased sales in New Jersey due to legalization of adult use sales which began on April 21, 2022, and growth in Illinois and Virginia. In addition, the Company also acquired a cultivation and processing facility in Minnesota since September 30, 2021.

Cost of goods sold are derived from ~~Retail~~retail purchases made by the Company from its third-party licensed producers operating within our state markets and costs related to the internal cultivation and production of cannabis. Cost of goods sold for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 was ~~$378,127~~$250,923 thousand, ~~up 32%~~an increase of 1% from ~~$286,685~~$248,173 thousand for the ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, driven by increased volume from open and operating Retail stores, new and acquired Retail store openings in Illinois, Maryland, Massachusetts, Minnesota, Nevada, and Virginia, and expansion of the consumer products sales primarily in Illinois and New Jerseyrevenue as described above.

Gross profit for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 was ~~$379,978~~$250,001 thousand, representing a gross margin on the sale of branded cannabis flower and processed and packaged products including concentrates, edibles, topicals and other cannabis products, of 50%. This is compared to gross profit for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 of ~~$363,294~~$248,738 thousand or a ~~56%~~50% gross margin. The increase in gross profit (dollars) was directly attributable to the revenue increase as described above.

Total expenses for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 were ~~$214,402~~$164,736 thousand or ~~28%~~33% of revenues, net of discounts, resulting in an increase of ~~$11,566~~$32,813 thousand over the same period in the prior year. Total expenses for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 were ~~$202,836~~$131,923 thousand or ~~31%~~27% of revenues, net of discounts. ~~The increase~~Total expenses were lower in ~~total expenses was attributable to Retail salaries and benefits, depreciation expense and other operational and facility expenses mainly as a result~~the first six months of the Company’s addition of five new and seven acquired retail stores over the prior year period. In addition, an increase in intangible amortization expense and corporate staff salaries contributed to the overall increase in total expenses which was partially offset by the remeasurement of the Company's contingent consideration arrangements associated with two acquisitions that occurred in 2021.

~~Total other income (expense) for the nine months ended September 30,~~ 2022 ~~was $1,429 thousand, a change of $7,369 thousand, mainly~~primarily due to favorable fair value adjustments associated with the Company's ~~acquisition~~contingent consideration arrangements, which were recorded during the six months ended June 30, 2022.

Total other income (expense) for six months ended June 30, 2023 was $(2,769) thousand a decrease of ~~ILDISP as well as the change in the fair value of~~$9,842 thousand, due to favorable adjustments to the Company's warrant liability, partially offset by unfavorable fair value adjustments onassociated with the Company's equity investments, both recorded during the ~~nine~~six months ended ~~September~~June 30, 2022.

Net operating income before provision for income taxes and non-controlling interest for ~~the nine~~six months ended ~~September~~June 30, ~~2022~~2023 was ~~$167,005~~$82,496 thousand, ~~an increase~~a decrease of ~~$12,487~~$41,392 thousand compared to the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022.

As presented under the heading “Non-GAAP Measures” below, after adjusting for non-cash equity incentive compensation of ~~$19,362~~$13,620 thousand and ~~$14,698~~$11,484 thousand, and other nonoperating (income) expenses, of ~~$(26,405)~~$5,430 thousand and ~~$9,425~~$(29,711) thousand in the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, respectively, Adjusted ~~Operating~~ EBITDA was ~~$230,239~~$152,050 thousand and ~~$231,820~~$145,776 thousand, ~~in the nine months ended September 30, 2022 and 2021,~~ respectively.

Income tax expense is recognized based on the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at year-end. For the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, federal and state income tax expense totaled ~~$102,440~~$59,401 thousand compared to expense of ~~$98,203~~$69,471 thousand for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~

Net income attributable to the Green Thumb Industries for the nine months ended September 30, 2022 was $63,205 thousand or $0.27 per basic and $0.26 per diluted share, compared to a net income of $52,630 thousand, or $0.24 per basic and $0.23 per diluted share in the same period in the prior year. The increase in net income of $10,575 thousand was primarily due to favorable fair value adjustments as reflected within other income (expense), net during the current year.2022.

The following table summarizes revenues net of sales discounts by segment for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021:~~2022:


		Three Months Ended September 30,							Three Months Ended June 30,				2023 vs. 2022
		2022		2021		$ Change	% Change		2023		2022		$ Change	% Change
		(in thousands)							(in thousands)				Increase (Decrease)
Retail	$	199,632	$	161,016	$	38,616	24%	$	188,044	$	192,734	$	(4,690)	(2)%
Consumer Packaged Goods		127,676		121,074		6,602	5%		136,054		120,604		15,450	13%
Intersegment Eliminations		(66,114)		(48,413)		(17,701)	37%		(71,710)		(59,027)		(12,683)	(21)%
Total Revenues, Net of Discounts	$	261,194	$	233,677	$	27,517	12%	$	252,388	$	254,311	$	(1,923)	(1)%

		Nine Months Ended September 30,
		2022		2021		$ Change	% Change
		(in thousands)
Retail	$	564,951	$	441,241	$	123,710	28%
Consumer Packaged Goods		368,692		343,014		25,678	7%
Intersegment Eliminations		(175,538)		(134,276)		(41,262)	31%
Total Revenues, Net of Discounts	$	758,105	$	649,979	$	108,126	17%

Three Months Ended ~~September~~June 30, ~~2022~~2023 Compared with the Three Months Ended ~~September~~June 30, ~~2021~~2022

Revenues, ~~Net~~net of ~~Discounts,~~discounts, for the Retail segment were ~~$199,632~~$188,044 thousand, ~~an increase~~a decrease of ~~$38,616~~$4,690 thousand or ~~24%~~2%, compared to the three months ended ~~September~~June 30, ~~2021.~~2022. The ~~increase~~Company increased the total number of units sold, but due to price compression, total revenue declined. This decrease was partially offset by continued growth in ~~Retail revenues,~~existing markets such as New Jersey, Virginia, and Connecticut, as well as revenue generated from new retail stores opened in the current period.

Revenues, net of discounts, was primarily driven by legalization of adult use in New Jersey, which began on April 21, 2022, as well as new store openings including acquired Retail stores in Illinois, Maryland, Massachusetts, Minnesota, Nevada and Virginia and increased store traffic to Green Thumb’s open and operating Retail stores, particularly in Illinois.

~~Revenues, Net of Discounts,~~ for the Consumer Packaged Goods ~~segment~~Segment were ~~$127,676~~$136,054 thousand, an increase of ~~$6,602~~$15,450 thousand or 5%13%, compared to the three months ended ~~September~~June 30, ~~2021.~~2022. The key ~~drivers~~driver for the increase in Consumer Packaged Goods revenues was increased sales in New Jersey due to legalization of adult use sales, which began on April 21, 2022, and continued growth in Illinois. In addition, the Company also acquired a cultivation and processing facility in Minnesota since September 30, 2021.production capacity within existing markets.

Intersegment eliminations associated with the Consumer Packaged Goods ~~segment~~Segment were ~~$(66,114)~~$71,710 thousand, an increase of ~~$(17,701)~~$12,683 thousand or ~~37%~~21% compared to the three months ended ~~September~~June 30, ~~2021.~~2022. The increase in intersegment eliminations was driven by increased intercompany sales to Company-owned ~~Retail stores as well as to newly acquired Retail stores as discussed above.~~retail stores. Consumer Packaged Goods revenues, net of intersegment eliminations, made up ~~24%~~25% of total revenues during the three months ended ~~September~~June 30, ~~2022~~2023 as compared to ~~31%~~24% during the three months ended ~~September~~June 30, ~~2021.~~2022.

Due to the vertically integrated nature of the business, the Company reviews its revenue at the Retail and Consumer Packaged Goods level while reviewing its operating results on a consolidated basis.

Six Months Ended ~~September~~June 30, ~~2022~~2023 Compared with the ~~Nine~~Six Months Ended ~~September~~June 30, ~~2021~~2022

Revenues, ~~Net~~net of ~~Discounts,~~discounts for the Retail segment were ~~$564,951,~~$376,922, an increase of ~~$123,710~~$11,602 or ~~28%~~3%, compared to the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022. The increase in Retail revenues, net of discounts, was primarily driven by legalization of ~~adult use~~adult-use sales in New Jersey, which began on April 21, 2022, continued growth in ~~Illinois, and new and acquired store openings in Illinois, Maryland, Massachusetts, Minnesota, Nevada~~existing markets such as Connecticut and Virginia, ~~and increased store traffic to Green Thumb’s open and operating Retail~~as well as revenue generated from new retail stores ~~particularly~~opened in ~~Illinois.~~the current period, partially offset by price compression.

Revenues, ~~Net~~net of ~~Discounts,~~discounts, for the Consumer Packaged Goods ~~segment~~Segment were ~~$368,692~~$261,671 thousand, an increase of ~~$25,678~~$20,655 thousand or 7%9%, compared to the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022. The key ~~drivers~~driver for the increase in Consumer Packaged Goods revenues was increased sales in New Jersey due to legalization of adult use sales, which began on April 21, 2022 and continued growth in Illinois. In addition, the Company also acquired a cultivation and processing facility in Minnesota since September 30, 2021.production capacity within existing markets.

Intersegment eliminations associated with the Consumer Packaged Goods ~~segment~~Segment were ~~$(175,538)~~$137,669 thousand, an increase of ~~$(41,262)~~$28,244 thousand or ~~31%~~26% compared to the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022. The increase in intersegment eliminations was driven by increased intercompany sales to Company-owned ~~Retail~~retail stores primarily in Illinois, Pennsylvania, and New Jersey as well as to newly acquired ~~Retail~~retail stores as discussed above. Consumer Packaged Goods revenues, net of intersegment eliminations, made up 25% of total revenues during the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 as compared to ~~32%~~26% during the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022.

Due to the vertically integrated nature of the business, the Company reviews its revenue at the Retail and Consumer Packaged Goods level while reviewing its operating results on a consolidated basis.

The Company derives its revenue from two revenue streams: a Consumer Packaged Goods business in which it manufactures, sells and distributes its portfolio of Consumer Packaged Goods brands including ~~&Shine,~~ Beboe, Dogwalkers, Dr. Solomon’s, Good Green, incredibles, and RYTHM, primarily to third-party customers; and a Retail business in which it sells finished goods sourced primarily from third-party cannabis manufacturers in addition to the Company’s own Consumer Packaged Goods products direct to the end consumer in its ~~Retail~~retail stores, as well as direct-to-consumer delivery where applicable by state law.

For the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, revenue was contributed from Consumer Packaged Goods and Retail sales across California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia.

Gross profit is revenue less cost of goods sold. Cost of goods sold includes the costs directly attributable to product sales and includes amounts paid for finished goods, such as flower, edibles, and concentrates, as well as packaging and other supplies, fees for services and processing, and allocated overhead which includes allocations of rent, utilities and related costs. Cannabis costs are affected by various state regulations that limit the sourcing and procurement of cannabis product, which may create fluctuations in gross profit over comparative periods as the regulatory environment changes. Gross margin measures our gross profit as a percentage of revenue.

During the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the Company continued to be focused on creating sustainable, profitable growth of the Company’s business ~~while pursuing expansion. Green Thumb expects to continue its growth strategy for the foreseeable future as the Company expands its Consumer Packaged Goods and Retail footprint~~ within its current markets ~~with acquisitions~~while considering strategic acquisition and ~~partnerships, and scales resources into new markets.~~partnership opportunities.

Total expenses other than the cost of goods sold consist of selling costs to support customer relationships and marketing and branding activities. It also includes a significant investment in the corporate infrastructure required to support the Company’s ongoing business.

Retail selling costs generally correlate to revenue. As new ~~locations~~stores begin operations, these ~~locations~~stores generally experience higher selling costs as a percentage of revenue compared to more established ~~locations,~~stores, which experience a more constant rate of selling costs. As a percentage of sales, the Company expects selling costs to remain constant in the more established ~~locations~~stores and increase in the newer ~~locations~~stores as ~~the~~ business continues to grow.

General and administrative expenses also include costs incurred at the Company’s corporate offices, primarily related to back office personnel costs, including salaries, incentive compensation, benefits, stock-based compensation and other professional service ~~costs.~~

costs, and fair value adjustments on the Company's contingent consideration arrangements. The Company expects to continue to invest considerably in this area to support ~~expansion plans~~the business by attracting and retaining top-tier talent. Furthermore, the ~~business.~~Company anticipates an increase in stock-based compensation expenses related to recruiting and hiring talent, along with legal and professional fees associated with being a publicly traded company in Canada and registered with the U.S. Securities and Exchange Commission.

The Company is subject to income taxes in the jurisdictions in which it operates and, consequently, income tax expense is a function of the allocation of taxable income by jurisdiction and the various activities that impact the timing of taxable events. As the Company operates in the federally illegal cannabis industry, it is subject to the limitations of the ~~U.S. Internal Revenue Code of 1986, as amended (“IRC”)~~IRC Section 280E, under which taxpayers are only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E and a higher effective tax rate than most industries. Therefore, the effective tax rate can be highly variable and may not necessarily correlate to pre-tax income or loss.

~~EBITDA, Adjusted Operating~~ EBITDA, and Adjusted EBITDA are non-GAAP measures and do not have standardized definitions under GAAP. The following information provides reconciliations of the supplemental non-GAAP financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. These supplemental non-GAAP financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented.


		Three Months Ended September 30,				Nine Months Ended September 30,				Three Months Ended June 30,				Six Months Ended June 30,
		2022		2021		2022		2021		2023		2022		2023		2022
		(in thousands)				(in thousands)				(in thousands)				(in thousands)
Net Income Before Non-Controlling Interest	$	10,148	$	21,586	$	64,565	$	56,315	$	13,690	$	24,731	$	23,095	$	54,417
Interest Income, net		(1,085)		(328)		(2,609)		(674)		(1,531)		(624)		(3,262)		(1,524)
Interest Expense, net		4,644		7,616		16,113		16,419		2,869		5,399		6,685		11,469
Provision For Income Taxes		32,969		37,320		102,440		98,203		25,765		38,340		59,401		69,471
Other Income (Expense), Net		2,085		(8,125)		(14,933)		(9,805)
Total Other (Income) Expense										270		(5,583)		(654)		(17,018)
Depreciation and amortization		24,518		17,173		71,706		47,239		24,234		24,198		47,735		47,188
Earnings before interest, taxes, depreciation and amortization (EBITDA) (non-GAAP measure)	$	73,279	$	75,242	$	237,282	$	207,697	$	65,297	$	86,461	$	133,000	$	164,003
Stock-based compensation, non-cash		7,878		4,995		19,362		14,698		7,381		6,833		13,620		11,484
Acquisition, transaction and other non-operating (income) costs		3,306		944		(26,405)		9,425		3,138		(14,557)		5,430		(29,711)
Adjusted Operating EBITDA (non-GAAP measure)	$	84,463	$	81,181	$	230,239	$	231,820
Adjusted EBITDA (non-GAAP measure)									$	75,816	$	78,737	$	152,050	$	145,776

As of ~~September~~June 30, ~~2022~~2023, and December 31, ~~2021,~~2022 the Company had total current liabilities of ~~$129,439~~$175,261 thousand and ~~$204,379~~$146,571 thousand, respectively, and cash and cash equivalents of ~~$147,258~~$149,026 thousand and ~~$230,420~~$177,682 thousand, respectively, to meet its current obligations. The Company had working capital of ~~$189,121~~$165,993 thousand as of ~~September~~June 30, ~~2022, an increase~~2023, a decrease of ~~$29,270~~$38,787 thousand as compared to December 31, ~~2021.~~2022. This ~~increase~~decrease in working capital was primarily driven by ~~an additional $55,000 thousand tenant improvement allowance provided~~purchases of property, plant, and equipment, as ~~part of~~well as tax payments made in the ~~third amendment to the lease of one of the Company's cultivation and processing facilities in Danville, Pennsylvania with Innovative Industrial Properties, Inc. (“IIP”).~~current period.

The Company is an early-stage growth company, generating cash from revenues, deploying its capital reserves to acquire and develop assets capable of producing additional revenues and earnings over both the immediate and long term. Capital reserves are primarily being utilized for capital expenditures, facility improvements, strategic investment opportunities, product development and marketing, as well as customer, supplier, and investor and industry relations.

While the Company's revenue, gross profit and operating income were not materially impacted by COVID-19 and the Company maintained the consistency of its operations during the first nine months of 2022, the effects of COVID-19 may impact the Company's business operations for reasons including the potential quarantine of employees or those of supply chain partners. The Company takes a cautious approach in allocating its capital to maximize its returns while ensuring appropriate liquidity. Given the current uncertainty of the future economic environment, the Company has taken additional measures in monitoring and deploying its capital to minimize the negative impact on its current operations and expansion plans.

Net cash provided by (used in) operating, investing and financing activities for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021,~~2022, were as follows:


		Nine Months Ended September 30,				Six Months Ended June 30,
		2022		2021		2023		2022
		(in thousands)				(in thousands)
Net Cash Provided by Operating Activities	$	88,220	$	82,767	$	93,028	$	39,914
Net Cash Used in Investing Activities	$	(161,168)	$	(148,280)	$	(131,542)	$	(114,296)
Net Cash Provided by (Used in) Financing Activities	$	(10,214)	$	267,547	$	9,858	$	(10,761)

As of ~~September~~June 30, ~~2022,~~2023, the Company does not have any off-balance-sheet arrangements that have, or are reasonably likely to have, a current or future effect on the results of operations or financial condition of the Company, including, and without limitation, such considerations as liquidity and capital resources.

Refer to the discussion of recently adopted/issued accounting pronouncements under Part I, Item 1, Notes to Unaudited Interim Condensed Consolidated Financial Statements, Note ~~1 -~~ 1—Overview and Basis of ~~Presentation of this Report.~~Presentation.

Critical Accounting Policies and Significant ~~Judgements~~Judgments and Estimates

There were no material changes to our critical accounting policies and estimates from the information provided in ~~Part II, Item 7,~~ “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included in ~~the 2021~~our 2022 Form 10-K.

ITEM 3. ~~QUANTITATIVE~~QUANTITAVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to our market risk disclosures as set forth in Part II Item 7A ~~“Quantitative and Qualitative Disclosures about Market Risk,” included in the 2021~~of our 2022 Form 10-K.

The Company's management carried out an evaluation under the supervision and with the participation of the Company's Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the ~~“Exchange Act”)~~Exchange Act). Based upon that evaluation, ~~management identified a material weakness in our internal control over financial reporting which was also disclosed in the 2021 Form 10-K. As a result of this material weakness,~~ management concluded that our disclosure controls and procedures were ~~not~~ effective as of ~~September~~June 30, ~~2022.~~

In response to the identified material weakness in the 2021 Form 10-K, the Company's management, with the oversight of the Audit Committee of the Company's Board of Directors, have developed a plan to remediate the material weakness including designing and implementing improved processes and internal controls with the intent of ensuring proper application of relevant accounting guidance. The Company took steps during the first three quarters of 2022 to enhance the control environment and will continue to evaluate these controls over the remainder of the year.2023.

~~Except as noted above, there~~There have been no changes in the Company's internal control over financial reporting during the ~~third~~second quarter of ~~2022~~2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, will be or have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

The Company is a party to a variety of legal proceedings that arise out of operations in the normal course of business. While the results of these legal proceedings cannot be predicted with certainty, the Company believes that the final outcome of these proceedings will not have a material adverse effect, individually or in the aggregate, on our results of operations or financial condition.

~~There have been no material changes to~~For a discussion of our potential risks and uncertainties, see the ~~risk factors disclosed~~information under the heading "Risk Factors" in ~~Part I, Item 1A, “Risk Factors,” of the 2021~~our 2022 Form 10-K.

~~During the three months ended September~~Between April 1, 2023 and June 30, ~~2022, shareholders of~~2023, the Company ~~converted 28,341 Multiple~~issued a total of 64,270 deferred shares associated with the Company's previous acquisitions of various privately held Companies.

On June 1, 2023, the Company issued 822,447 Subordinate Voting Shares ~~into 2,834,100 Subordinate Voting Shares.~~as contingent consideration associated with the Company's July 2021 acquisition of Dharma Pharmaceuticals, LLC.

During the three months ended September 30, 2022, shareholders of the Company converted 28,341 Super Voting Shares into 28,341 Multiple Voting Shares and 28,341 Multiple Voting Shares into 2,834,100 Subordinate Voting Shares.None.

~~During the three months ended September 30, 2022, shareholders of the Company converted 28,341 Super Voting Shares into 28,341 Multiple Voting Shares.~~None.

Pursuant to requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


British Columbia	98-1437430
(State or other jurisdiction of incorporation or organization)	(I.R.S. employer identification no.)

325 West Huron Street, Suite 700 Chicago, Illinois	60654
(Address of principal executive offices)	(zip code)


FINANCIAL INFORMATION		Page
	Part I
ITEM 1:	Unaudited Interim Condensed Consolidated Balance Sheets as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022	4
	Unaudited Interim Condensed Consolidated Statements of Operations for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022	5
	Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022	6
	Unaudited Interim Condensed Consolidated Statements of Cash Flows for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~2021~~2022	8
	Notes to Unaudited Interim Condensed Consolidated Financial Statements	10
ITEM 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3328
ITEM 3:	Quantitative and Qualitative Disclosure About Market Risk	4336
ITEM 4:	Controls and Procedures	4336
	Part II
OTHER INFORMATION
ITEM 1:	Legal Proceedings	4437
ITEM 1a:	Risk Factors	4437
ITEM 2:	Sale of Unregistered Securities	4437
ITEM 3:	Defaults Upon Senior Securities	4437
ITEM 4:	Mine Safety Disclosure	4437
ITEM 5:	Other Information	4437
ITEM 6:	Exhibits	4538
Signatures		4639


		September 30, 2022		December 31, 2021		June 30, 2023		December 31, 2022
		(in thousands)				(in thousands)
Raw Material	$	2,667	$	5,278	$	1,530	$	3,070
Packaging and Miscellaneous		10,105		8,622		10,695		9,847
Work in Process		56,946		42,403		52,536		57,287
Finished Goods		55,724		41,069		64,391		49,268
Reserve for Obsolete Inventory		(3,520)		(1,901)		(4,380)		(3,797)
Total Inventories	$	121,922	$	95,471
Total Inventories, Net					$	124,772	$	115,675


		September 30, 2022		December 31, 2021		June 30, 2023		December 31, 2022
		(in thousands)				(in thousands)
Buildings and Improvements	$	130,806	$	101,283	$	187,824	$	176,874
Equipment, Computers and Furniture		113,897		83,281		134,705		122,568
Leasehold Improvements		134,674		114,303		156,340		135,524
Land Improvements		822		607		847		847
Capitalized Interest		13,929		6,523		26,546		16,934
Total Property and Equipment		394,128		305,997		506,262		452,747
Less: Accumulated Depreciation		(70,878)		(45,198)		(101,942)		(80,702)
Property and Equipment, net		323,250		260,799		404,320		372,045
Land		23,743		20,258		33,725		29,106
Assets Under Construction		151,355		128,017		236,913		156,722
Property and Equipment, net	$	498,348	$	409,074	$	674,958	$	557,873


			Fair Value
		Warrants	September 30,	December 31,
Warrants Included in Contributed Surplus	Strike Price	Outstanding	2022	2021
			(in thousands)
Mortgage Warrants Issued June 2020	$9.10	35,000	$181	$181
Private Placement Refinance Warrants Issued April 2021	$32.68	1,459,044	22,259	22,259
Private Placement Refinance Warrants Issued October 2021	$30.02	243,303	2,616	2,616
Totals		1,737,347	$25,056	$25,056


Large accelerated filer	☒	Accelerated filer	☐

Non-accelerated filer	☐	Smaller reporting company	☐

Emerging growth company	☐


		Share Capital			Contributed Surplus (Deficit)				Deferred Share Issuance				Accumulated Earnings (Deficit)				Non-Controlling Interest				Total
		(in thousands)
Balance, July 1, 2021	$		1,316,465	$		13,159		$		8,566		$		(113,079	)	$		4,046		$		1,229,157
Issuance of shares for redemption of noncontrolling interest			4,070			(4,996	)			—				—				926				—
Issuance of shares under business combinations and investments			166,164			60				—				—				—				166,224
Shares issued as contingent consideration			5,949			—				—				—				—				5,949
Issuance of deferred shares			—			—				21,382				—				—				21,382
Distribution of deferred shares			1,319			—				(1,303	)			—				—				16
Exercise of options, RSUs and warrants			6,897			(4,640	)			—				—				—				2,257
Stock-based compensation			—			4,995				—				—				—				4,995
Distributions to limited liability company unit holders			—			—				—				—				(6,452	)			(6,452	)
Net income			—			—				—				20,210				1,376				21,586
Balance, September 30, 2021	$		1,500,864	$		8,578		$		28,645		$		(92,869	)	$		(104	)	$		1,445,114
Balance, January 1, 2021	$		1,048,640	$		4,893		$		2,587		$		(145,499	)	$		3,537		$		914,158
Issuance of shares for redemption of noncontrolling interest			4,070			(4,996	)			—				—				926				—
Issuance of shares under business combinations and investments			223,957			22				—				—				—				223,979
Shares issued as contingent consideration			18,622			—				—				—				—				18,622
Issuance of deferred shares			—			—				29,196				—				—				29,196
Distribution of deferred shares			3,145			—				(3,138	)			—				—				7
Issuance of registered shares pursuant to Form S-1			155,803			(305	)			—				—				—				155,498
Exercise of options, RSUs and warrants			39,221			(27,993	)			—				—				—				11,228
Stock-based compensation			—			14,698				—				—				—				14,698
Warrants and shares issued in association with note payable			271			22,259				—				—				—				22,530
Shares issued for settlement of business obligation			7,135			—				—				—				—				7,135
Distributions to limited liability company unit holders			—			—				—				—				(8,252	)			(8,252	)
Net income			—			—				—				52,630				3,685				56,315
Balance, September 30, 2021	$		1,500,864	$		8,578		$		28,645		$		(92,869	)	$		(104	)	$		1,445,114


		Retail		Consumer Package Goods		Total
		(in thousands)
As of December 31, 2021	$	274,811	$	358,038	$	632,849
Acquisition of ILDISP, LLC		7,718		—		7,718
Adjustments to Preliminary Purchase Price Allocations		3,776		242		4,018
As of September 30, 2022	$	286,305	$	358,280	$	644,585


					Issuance Date Fair Value
			Warrants		June 30,		December 31,
Warrants Included in Contributed Surplus	Strike Price		Outstanding		2023		2022
					(in thousands)
Mortgage Warrants Issued June 2020	$	9.10		35,000	$	181	$	181
Private Placement Refinance Warrants Issued April 2021	$	32.68		1,459,044		22,259		22,259
Private Placement Refinance Warrants Issued October 2021	$	30.02		243,303		2,616		2,616
Totals				1,737,347	$	25,056	$	25,056


Significant Assumptions	Private Placement Refinancing Warrants	Private Placement Refinancing Warrants	Dispensary Mortgage Warrants
Date of Issuance	October 15, 2021	April 30, 2021	June 5, 2020
Volatility	73%	73%	80%
Estimated Term	4 years	4 years	5 years
Risk Free Rate	1.12%	0.74%	0.37%


Related Acquisition	As at December 31, 2022	Distributed Shares	Cancelled Shares	As at June 30, 2023
Liberty Compassion, Inc.	214,768	(214,768)	—	—
Dharma Pharmaceuticals, LLC	229,878	(229,878)	—	—
Mobley Pain Management and Wellness Center, LLC and Canwell Processing, LLC	264,760	(12,305)	(84,122)	168,333
GreenStar Herbals, Inc.	161,306	(161,306)	—	—
Maryland Health and Wellness Center, Inc.	61,832	(61,832)	—	—
LeafLine Industries, LLC	386,002	—	—	386,002
Total	1,318,546	(680,089)	(84,122)	554,335


	Number of Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Life

Balance as of December 31, 2022	9,577,947	$12.71	4.80
Granted	2,172,481	7.75	6.73
Exercised	(130,508)	7.03
Forfeited	(745,869)	10.75
Balance as of June 30, 2023	10,874,051	$11.92	4.69
Vested	5,666,427	$14.91
Exercisable of June 30, 2023	1,096,059	$6.56	2.04


	Number of Shares		Weighted Average Grant Date Fair Value
Unvested Shares at December 31, 2022	947,502	$	17.91
Granted	3,092,835		7.65
Forfeited	(235,156)		11.64
Vested	(351,721)		15.78
Unvested Shares at June 30, 2023	3,453,460	$	9.37


	Number of Shares		Weighted Average Grant Date Fair Value
Unvested Shares at December 31, 2021	376,127	$	15.55
Granted	1,088,353		18.17
Forfeited	(123,454)		18.63
Vested	(388,273)		14.18
Unvested Shares at September 30, 2022	952,753	$	18.36


		ILDISP, LLC		Other Non-material VIEs		ILDISP, LLC		Other Non-material VIEs
		September 30, 2022				December 31, 2021
		(in thousands)				(in thousands)
Current assets	$	—	$	648	$	4,118	$	1,033
Non-current assets		—		1,974		3,290		1,761
Current liabilities		—		419		10,719		854
Non-current liabilities		—		622		413		696
Noncontrolling interests		—		279		(1,862)		224
Equity attributable to Green Thumb Industries Inc.		—		1,302		(1,862)		1,020


	June 30,	December 31,
	2023	2022
Risk-free interest rate	3.06% - 3.64%	1.18% - 3.54%
Expected dividend yield	0%	0%
Expected volatility	64%	60% - 64%
Expected option life	3.5 – 4.5 years	3 – 4.5 years


		Three Months Ended
		September 30, 2022				September 30, 2021
		ILDISP, LLC		Other Non-material VIEs		ILDISP, LLC		Other Non-material VIEs
		(in thousands)				(in thousands)
Revenues, Net of Discounts	$	—	$	2,306	$	6,331	$	3,981
Net income attributable to noncontrolling interests		—		319		1,017		359
Net income attributable to Green Thumb Industries Inc.		—		269		1,017		713
Net income	$	—	$	588	$	2,034	$	1,072

		Nine Months Ended
		September 30, 2022				September 30, 2021
		ILDISP, LLC		Other Non-material VIEs		ILDISP, LLC		Other Non-material VIEs
		(in thousands)				(in thousands)
Revenues, Net of Discounts	$	3,543	$	6,805	$	18,275	$	11,115
Net income attributable to noncontrolling interests		462		898		2,658		1,027
Net income attributable to Green Thumb Industries Inc.		462		761		2,658		1,602
Net income	$	924	$	1,659	$	5,316	$	2,629


31.1	CERTIFICATE OF CHIEF EXECUTIVE OFFICER

31.2	CERTIFICATE OF CHIEF FINANCIAL OFFICER

32.1	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

32.2	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

101.INS	Inline XBRL Instance Document

101.SCH	Inline XBRL Taxonomy Extension Schema Document

101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document

104	Cover Page Interactive Data File (embedded with Inline XBRL File)